~~UNITED~~ ~~STATES~~ 0001126162 false 2022 FY ~~SECURITIES~~ ~~AND~~ 0001126162 2021-12-01 2022-11-30 0001126162 2022-11-30 0001126162 2021-11-30 0001126162 2020-12-01 2021-11-30 0001126162 us-gaap:CommonStockMember 2020-11-30 0001126162 gbiq:ShareToBeIssuedMember 2020-11-30 0001126162 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001126162 us-gaap:RetainedEarningsMember 2020-11-30 0001126162 2020-11-30 0001126162 us-gaap:CommonStockMember 2021-11-30 0001126162 gbiq:ShareToBeIssuedMember 2021-11-30 0001126162 us-gaap:AdditionalPaidInCapitalMember 2021-11-30 0001126162 us-gaap:RetainedEarningsMember 2021-11-30 0001126162 us-gaap:CommonStockMember 2020-12-01 2021-11-30 0001126162 gbiq:ShareToBeIssuedMember 2020-12-01 2021-11-30 0001126162 us-gaap:AdditionalPaidInCapitalMember 2020-12-01 2021-11-30 0001126162 us-gaap:RetainedEarningsMember 2020-12-01 2021-11-30 0001126162 us-gaap:CommonStockMember 2021-12-01 2022-11-30 0001126162 gbiq:ShareToBeIssuedMember 2021-12-01 2022-11-30 0001126162 us-gaap:AdditionalPaidInCapitalMember 2021-12-01 2022-11-30 0001126162 us-gaap:RetainedEarningsMember 2021-12-01 2022-11-30 0001126162 us-gaap:CommonStockMember 2022-11-30 0001126162 gbiq:ShareToBeIssuedMember 2022-11-30 0001126162 us-gaap:AdditionalPaidInCapitalMember 2022-11-30 0001126162 us-gaap:RetainedEarningsMember 2022-11-30 0001126162 srt:ScenarioPreviouslyReportedMember 2021-11-30 0001126162 srt:RestatementAdjustmentMember 2021-11-30 0001126162 gbiq:AsRestatedMember 2021-11-30 0001126162 srt:ScenarioPreviouslyReportedMember 2020-12-01 2021-11-30 0001126162 srt:RestatementAdjustmentMember 2020-12-01 2021-11-30 0001126162 gbiq:AsRestatedMember 2020-12-01 2021-11-30 0001126162 us-gaap:CommonStockMember 2019-11-30 0001126162 gbiq:ShareToBeIssuedMember 2019-11-30 0001126162 us-gaap:AdditionalPaidInCapitalMember 2019-11-30 0001126162 us-gaap:RetainedEarningsMember 2019-11-30 0001126162 2019-11-30 0001126162 us-gaap:CommonStockMember 2019-12-01 2020-11-30 0001126162 gbiq:ShareToBeIssuedMember 2019-12-01 2020-11-30 0001126162 us-gaap:AdditionalPaidInCapitalMember 2019-12-01 2020-11-30 0001126162 us-gaap:RetainedEarningsMember 2019-12-01 2020-11-30 0001126162 2019-12-01 2020-11-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure ~~EXCHANGE COMMISSION~~

~~Washington, D.C. 20549~~UNITED STATES

~~Form~~SECURITIES AND ~~10-K~~EXCHANGE COMMISSION

~~[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES~~WASHINGTON, ~~EXCHANGE~~D.C. ~~ACT OF 1934~~20549

~~For the fiscal year ended November 30, 2013~~FORM 10-K

~~Commission File Number 000-33271~~(Mark One)

☒	ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

for the fiscal year ended November 30, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transaction period from ____ to ____

Commission File No. 000-33271

PURTHANOL RESOURCES LIMITED

(~~Formerly~~Exact name ~~GLOBAL~~of ~~BIOTECH~~registrant ~~CORP.~~as specified in its charter)

Delaware		98-022951
Wyoming		98-0229951
(State or Other Jurisdiction of		(I.R.S. Employer
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
Incorporation or Organization)		Identification No.)

Address of Principal Executive Offices)

2711 Centreville Rd Suite 400

Wilmington, Delaware 19808

~~Issuer's~~(Address of ~~telephone~~principal ~~number:~~executive ~~(302)~~offices, ~~288-0658~~Zip Code)

~~Securities registered pursuant to Section 12~~ (b866) ~~of the Act: None~~ 351-4141

~~Securities registered pursuant to Section 12~~ (~~g) of the Act: Common~~Registrant’s ~~stock,~~telephone ~~par value $0.0001 per share Preferred stock~~number, ~~par~~including ~~value~~area ~~$0.0001 per share~~code)

~~Indicate by check mark whether the registrant is a well-known seasoned~~Securities ~~issuer~~registered aspursuant ~~defined~~to inSection ~~Rule~~12(b) ~~405~~ of the ~~Securities~~Exchange Act~~- [x] NO~~:

~~Indicate~~Title byof ~~check~~Class ~~mark~~Trading ifName ~~the~~of ~~registrant~~each isexchange ~~not~~on ~~required~~which toregistered ~~file reports~~Symbols ~~pursuant~~N/A toN/A ~~Section 13 or~~PURT

15Securities registered pursuant to section 12(dg) of the Act~~- [x] NO~~:

~~Check whether the issuer (1) filed all reports required to be filed~~Common by Section 13 or 15 (d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days -Yes |X|stock

~~Indicate by check mark whether the registrant has submitted electronically~~(Title ~~and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405~~ of ~~Regulation~~each ~~S-T (§ 232.405 of this chapter~~class) ~~during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [ ] Yes [X] No~~

~~Check if there is no disclosure of delinquent filers, pursuant to~~Indicate ~~Item~~by ~~405~~check ofmark ~~Regulation~~if ~~S-K, is not contained in this form, and no disclosure will be contained, to~~ the ~~best of~~ registrant's ~~knowledge, in~~is ~~definitive~~a ~~proxy~~well-known orseasoned ~~information~~issuer, ~~statements~~as ~~incorporated~~defined ~~by reference~~ in ~~Part~~Rule 3405 of ~~this~~the ~~Form~~Securities ~~10-K~~Act. or☐ ~~any amendment to this Form~~Yes ~~10-K-~~ ☒ ~~NO [x]~~No

~~Table~~Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of ~~Contents~~the Act. ☐ Yes ☒ No

Indicate by check mark whether the registrant is(1) ahas ~~large~~filed ~~accelerated filer,~~all anreports ~~accelerated~~required ~~filer,~~to abe ~~non-accelerated~~filed ~~filer,~~by orSection a13 ~~smaller~~or ~~reporting~~15(d) ~~company.~~of ~~See~~ the ~~definitions~~Securities Exchange Act of ~~“large~~1934 ~~accelerated filer,”~~during ~~“accelerated~~the ~~filer”~~preceding ~~and~~12 ~~“smaller~~months ~~reporting~~(or ~~company”~~for insuch ~~Rule~~shorter ~~12b-2~~period ofthat the ~~Exchange~~registrant ~~Act.~~was ~~[ ]~~required ~~Large~~to ~~accelerated~~file ~~filer~~such [reports), ]and ~~Accelerated~~(2) has ~~filer~~been [subject ]to ~~Non-accelerated~~such ~~filer~~filing ~~(Do~~requirements ~~not~~for ~~check~~the ifpast a90 ~~smaller~~days. ~~reporting~~☐ ~~company)~~Yes ☒ ~~[X] Smaller reporting company~~No

Indicate by check mark whether the registrant ishas asubmitted ~~shell~~electronically, ~~company (as~~if ~~determined~~any, inevery Interactive Data File required to be submitted pursuant to Rule ~~12b~~405 of Regulation S-2T (§ 232.405 of this chapter) during the ~~Exchange~~preceding ~~Act~~12 months (or for such shorter period that the registrant was required to submit such files). -☒ NOYes ☐ ~~[x]~~No

~~Issuer's~~Indicate by ~~revenues~~check ~~for~~mark ~~its~~if ~~most~~disclosure ~~recent~~of ~~fiscal~~delinquent ~~year:~~filers ~~$312~~pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein,~~200~~ and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒ Yes ☐ No

AsIndicate by ofcheck ~~March~~mark 13whether the registrant is a large accelerated filer, ~~2014~~an accelerated filer, ~~the~~a ~~aggregate~~non-accelerated ~~market~~filer, ~~value~~or ofa ~~the~~smaller ~~issuer's~~reporting ~~common~~company. ~~stock~~See ~~based~~the ondefinitions ~~its~~of ~~reported~~“large ~~price~~accelerated onfiler,” ~~the~~“accelerated ~~OTC~~filer” ~~Bulletin~~and ~~Board~~“smaller ~~held~~reporting bycompany” in ~~non~~Rule 12b-~~affiliates~~2 of the ~~issuer~~Exchange ~~was approximately $2,776,858~~Act.

AtLarge ~~March~~accelerated ~~13,~~filer ~~2014~~☐ ~~185,123,890~~Non-accelerated ~~shares~~filer of☐ ~~issuer's~~Accelerated ~~common~~filer ~~stock were~~☐ ~~outstanding~~Smaller reporting company ☒ Emerging growth company. ☒

~~Table~~If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of ~~Contents~~the 2Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). [X] Yes [ } No

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. N/A 0

(APPLICABLE ONLY TO CORPORATE REGISTRANTS)

As of November 30, 2022, the Company has 244,038,890 shares of common stock issued and outstanding.

PURTHANOL RESOURCES LIMITED

( Formerly GLOBAL BIOTECH CORP.)

FORM 10-K ANNUAL REPORT

TABLE OF CONTENTS

SECTION
ITEM 1. BUSINESS	4
PART 1			4
ITEM 2. PROPERTIES	6
Item 1.		Business	4
ITEM 3. LEGAL PROCEEDINGS	6
Item 2.		Properties	9
ITEM 4. MINE SAFETY DISCLOSURES	6
Item 3.		Legal Proceedings	9
Part II	6
Item 4.		Mine Safety disclosures	9
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES	6
PART 2			9
ITEM 6. SELECTED FINANCIAL DATA	8
Item 5.		Market for Registrant's Common Equity and Related Stockholders’ Matters and Issuer Purchases of Equity Securities	9
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	8
Item 6.		Selected Financial Data	12
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	9
Item 7.		Management's Discussion and Analysis of Financial Condition and Results of Operation	12
Item 8. Financial Statements	13
Item 7A		Quantitative and Qualitative Disclosures about Market Risk	14
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES	26
Item 8.		Financial Statements and Supplementary Data	14
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE	28
Item 9.		Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.	14
Our executive officers and director are as follows:	28
Item 9A.		Controls and Procedures	15
ITEM 11. EXECUTIVE COMPENSATION	30
Item 9B.		Other Information	16
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	31
PART 3			16
ITEM 13. CERTAIN RELATIONSHIP AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.	32
Item 10.		Directors, Executive Officers and Corporate Governance	16
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.	32
Item 11.		Executive Compensation	18
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES	33
Item 12.		Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	19
SIGNATURES	33
Item 13.		Certain Relationship and Related Transactions, and Director Independence	20
Item 14.		Principal Accountant Fees and Services	20
PART 4			20
Item 15.		Exhibits, Financial Statement Schedule	20

~~Table of Contents 3~~Forward-Looking Statements

~~ANNEX~~This Annual 1Report on Form 10-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions, forward-looking statements may include words such as “anticipate,” “believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,” “seek,” “plan,” “might,” “will,” “expect,” “anticipate,” “predict,” “project,” “forecast,” “potential,” “continue” negatives thereof or similar expressions. Forward-looking statements speak only as of the date they are made, are based on various underlying assumptions and current expectations about the future and are not guarantees. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or achievement to be materially different from the results of operations or plans expressed or implied by such forward-looking statements.

~~DESCRIPTION~~We cannot OFpredict ~~BUSINESS~~all of the risks and uncertainties. Accordingly, such information should not be regarded as representations that the results or conditions described in such statements or that our objectives and plans will be achieved, and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. These forward-looking statements are found at various places throughout this Annual Report on Form 10-K and include information concerning possible or assumed future results of our operations, including statements about potential acquisition or merger targets; business strategies; future cash flows; financing plans; plans and objectives of management; any other statements regarding future acquisitions, future cash needs, future operations, business plans and future financial results, and any other statements that are not historical facts.

(These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a) ~~Business~~different ~~Development~~extent or at a different time than we have described. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of the Annual Report on Form 10-K. All subsequent written and oral forward-looking statements concerning other matters addressed in this Annual Report on Form 10-K and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this Annual Report on Form 10-K.

~~GLOBAL~~Except to ~~BIOTECH~~the ~~CORP.~~extent ~~("Global")~~required by law, ~~formerly~~we ~~(Sword~~undertake ~~Comp-Soft Corp.)~~no ~~was~~obligation ~~organized~~to onupdate ~~November~~or 2,revise ~~1998.~~any ~~Its~~forward-looking ~~goal~~statements, ~~was~~whether toas ~~bring~~a ~~interactive~~result ~~healthcare~~of new information, ~~services~~future ~~utilizing~~events, ~~the~~a ~~Internet to~~change ~~the~~in ~~consumer~~events, ~~the end user~~conditions, tocircumstances ~~access~~or ~~what~~assumptions ~~they,~~underlying assuch ~~individuals~~statements, ~~need~~or otherwise.

~~As of March 5, 2003 this business was sold along with the assumption~~PART of a note payable in the amount of $700,000 to Millenia Hope Inc., its former parent corporation. Global’s vehicle tracking system was supposed to seamlessly tie together wireless communications and the Internet. As of February 24, 2005,Global concluded that this venture was unsuccessful. On August 15, 2007 Global acquired from Advanced Fluid Technologies Inc. a Delaware corporation, assets pursuant to entering the bottled water, more specifically the oxygenated bottled water, market. The corporation has not abandoned this business segment, but is now concentrating its efforts on its current acquisition.I

~~On September 10, 2013, Global acquired from~~ITEM ~~Purthanol International Ltd~~1. their know-how and all technical aspects of the Purthanol extraction process, the two (2) purchase orders on hand (for forward delivery of Athanol, Purthanol’s ethanol product, within the next 12 months, or later if agreed to by both parties). The consideration for all the above was 70 million newly issued common shares of Global valued at $700,000. A part of said agreement is a non-compete clause with Global.BUSINESS

~~(b) Business of Issuer~~Corporate History

~~Global’s primary mission is to use the Purthonal process~~Purthanol ~~methodology,~~Resources ~~acquired in September 2013~~Limited, toa ~~produce~~Delaware ancorporation ~~ethanol fuel alternative~~(“Purthanol”, ~~our~~the ~~product named Athanol~~“Company, ~~in order to fulfill 2 orders on hand totaling $28.5 million USD. These orders are not contractual obligations~~“we”, in“us” ~~any~~or ~~form. Should the~~“our”) ~~Company~~is ~~not~~a ~~fulfill~~public ~~these~~shell ~~orders,~~company ~~there~~seeking ~~are~~to nocreate ~~penalties~~value ~~attached or other non-performance compensation due. These orders are due~~ for ~~delivery~~its ~~within~~shareholders 12by ~~months~~merging ~~and~~with weanother ~~may~~entity ~~not~~with beexperienced ~~able~~management ~~to fully satisfy them~~ and ~~the customers may not agree to extend the~~ ~~deliver~~opportunities ~~time.~~for ~~Nonetheless,~~growth atin ~~the~~return ~~least the customer will compensate us~~ for ~~whatever~~shares ~~is delivered to that date. Further, based on informal discussions with the customers they have indicated that they are very eager to get deliveries~~ of ~~the product~~our ~~and~~common ~~expect that extending the orders should not be a problem~~stock. ~~While the Company believes this to be the case, there is no certainty that it will transpire this way.~~

~~Ethanol~~No potential ~~Product~~merger ~~Environmental~~candidate ~~Benefits~~has been identified at this time.

~~Ethanol is one of the best tools we have to fight air pollution~~We ~~from~~do ~~vehicles.~~not ~~And~~propose ~~there is no fuel available at scale today that matches ethanol's ability~~ to ~~improve~~restrict ~~overall~~our ~~environmental~~search ~~quality compared~~for toa ~~gasoline.~~business ~~From~~opportunity ~~its biodegradable nature~~ to ~~reductions~~any inindustry ~~greenhouse~~or ~~gas~~geographical area and ~~tailpipe~~may, ~~emissions~~therefore, ~~ethanol~~engage ~~provides~~in aessentially ~~tool~~any tobusiness ~~address environmental concerns. Ethanol contains 35% oxygen. Adding oxygen to fuel results~~ in aany ~~more complete fuel combustion, reducing harmful tailpipe emissions and helps to displace the use of toxic gasoline components such as benzene, a carcinogen~~industry. ~~Ethanol is~~We ~~a renewable fuel produced from plants, unlike petroleum-based fossil fuels that~~ have aunrestricted ~~limited~~discretion ~~supply~~in ~~and~~seeking ~~are the major contributor of carbon dioxide (CO2) emissions, a greenhouse gas (GHG). Independent analyses comparing ethanol~~ and ~~gasoline~~participating ~~show~~in ethanol reduces GHG emissions from 30-50%. A study published by Yale University's Journal of Industrial Ecology found that GHG emissions from ethanol produced at modern dry-mill facilities are "... equivalent to a 48business ~~percent to 59 percent reduction compared to gasoline~~opportunity, ~~a twofold~~subject to ~~threefold greater reduction than reported in previous studies. In 2012,~~ the ~~13.2 billion~~ ~~gallons~~availability of ~~ethanol~~such ~~produced~~opportunities, ~~reduced~~economic greenhouse gas emissions from on-road vehicles by 33.4 million tons. That's equivalent to removing 5.2 million vehicles from the road for one year. According to a University of California-Berkeley studyconditions, ~~"Ethanol Can Contribute to Energy~~ and ~~Environmental~~other ~~Goals," the production of ethanol reduces petroleum use 95% as compared to gasoline refining~~factors.

~~Table~~The selection of ~~Contents~~a 4business opportunity in which to participate is complex and risky. Additionally, we have only limited resources and may find it difficult to locate good opportunities. There can be no assurance that we will be able

~~Using ethanol helps lower gasoline prices by expanding gasoline~~to ~~supplies~~identify and ~~reducing~~acquire ~~the~~any ~~need~~business ~~for~~opportunity ~~importing~~which ~~expensive,~~will ~~high-octane,~~ultimately ~~petroleum-based~~prove ~~gasoline~~to ~~components~~be orbeneficial ~~more crude oil. Adding some 13 billion gallons~~ to ~~the~~us ~~nation's motor fuel pool -~~ and ~~blending~~our ~~it with gasoline in E10 - has a similar effect to the U~~shareholders.~~S. oil~~ ~~industry~~We ~~finding~~will ~~a way to extract 10% more gasoline from a barrel of oil. Since the supply of motor fuel is increased,~~select ~~there~~any ispotential abusiness ~~downward~~opportunity ~~pressure~~based on ~~prices. A~~our study by Iowa State University and the University of Wisconsin found that in 2010, domestic ethanol production helped keep gasoline prices $0.89 lower per gallon than they otherwise would have been. For the first decade of the 2000management’s, ~~the~~best ~~researchers~~business found ethanol’s price-lowering impact averages $0.25 per gallon. Source: “The Impact of Ethanol Production on US and Regional Gasoline Markets: An Update to May 2009,” Xiaodong Du and Dermot J. Hayes, April 2011. A May 2010 report found that the average American household is saving approximately $200-400 per year on gasoline because of ethanol's inclusion in the U.S. fuel supply.judgment

~~MARKET~~Our activities are subject to several significant risks, which arise primarily as a result of the fact that we have no specific business and may acquire or participate in a business opportunity based on the decision of management, which potentially could act without the consent, vote, or approval of our shareholders. The risks faced by us are further increased because of its lack of resources and our inability to provide a prospective business opportunity with significant capital.

~~Today, ethanol is blended in nearly every gallon of unleaded gasoline sold in the U.S.~~ 4

Annual Fuel Ethanol Production by Country (2007–2011) Top 10 countries/regional blocks (Millions of U.S. liquid gallons per year)
World rank	Country/Region	2011	2010	2009	2008	2007
1	United States	13,900	13,231	10,938	9,235	6,485
2	Brazil	5,573.24	6,921.54	6,577.89	6,472.2	5,019.2
3	European Union	1,199.31	1,176.88	1,039.52	733.60	570.30
4	China	554.76	541.55	541.55	501.90	486.00
5	Thailand			435.20	89.80	79.20
6	Canada	462.3	356.63	290.59	237.70	211.30
7	India			91.67	66.00	52.80
8	Colombia			83.21	79.30	74.90
9	Australia	87.2	66.04	56.80	26.40	26.40
10	Other			247.27
	World Total	22,356.09	22,946.87	19,534.993	17,335.20	13,101.7

History of the Company

~~Table~~We were organized and incorporated in the State of ~~Contents~~Delaware 5on November 2, 1998, under the name Sword Comp-Soft Corp. as an (ASP) Application Service Provider, specializing in the E-Healthcare sector, which said business was sold in 2003.Following the Company’s attempts to enter the vehicle tracking business were unsuccessful, the Company entered into a provisional agreement with Advance Fluid Technologies, Inc., a Delaware Corporation via a letter of Intent, to acquire assets from the latter corporation, pursuant to entering the bottled water, more specifically the oxygenated bottled water market.

U.S. production and imports (2001–2010) (Millions of U.S. liquid gallons)
Year	Production	Imports	Demand
2001	1,770	n/a	n/a
2002	2,130	46	2,085
2003	2,800	61	2,900
2004	3,400	161	3,530
2005	3,904	135	4,049
2006	4,855	653	5,377
2007	6,500	450	6,847
2008	9,000	556	9,637
2009	10,600	190	10,940
2010	13,230	10	13,184

On August 26, 2005, the Company finalized this agreement with Advanced Fluid Technologies to purchase their to be patented oxygenation unit and all technical know-how, intellectual properties, methodologies and all information pertaining to the following: the fixation of the oxygen molecule to water or any other fluid and/or to the building and maintenance of the oxygenation unit. Furthermore, all trademarks for the name AquaBoost Oxygenated Water, currently no longer in force in the U.S., Canada, and Mexico and the right to use and register said name globally, were transferred to the Company are worthless. Also, included was a distribution contract between Advanced Fluid Technologies and ImporTadora Comercializadora Maple S.A. of Mexico, which Advanced Fluid transferred to the Company which has been rendered null.

~~PURTHANOL’S~~On April ~~ETHANOL~~4, ~~PRODUCT-ATHANOL~~2006, we filed a Certificate of Amendment in the state of Delaware changing our name to Global Biotech Corp. (“Global”).

~~Athanol,~~On August ~~unlike most ethanol products produced from corn~~15, ~~is produced from sweet sorghum~~2007, ~~historically~~Global ~~cultivated~~acquired asfrom aAdvanced ~~source~~Fluid ofTechnologies ~~sugar~~Inc. Ina ~~1853~~Delaware corporation, ~~the~~assets ~~crop~~pursuant ~~was introduced~~ to ~~North~~entering ~~American~~the ~~from~~bottled ~~Tropical~~water, ~~Africa. Owing~~more tospecifically ~~its origins,~~ the ~~species~~oxygenated isbottled awater, ~~hardy~~market. ~~crop,~~The ~~capable~~corporation ofhas ~~growing~~abandoned inthis ~~harsh~~business ~~environments~~segment however, ~~such~~the ~~as hot~~Company ~~and~~ceased ~~dry~~all ~~regions~~operations ofon ~~the~~November ~~world. Thus~~30, ~~sweet~~2015. ~~sorghum~~The Company is ~~better~~now ~~suited~~concentrating ~~than~~its ~~corn~~efforts ason afuture ~~source~~unspecified ~~of renewal fuel in regions where corn is poorly adapted~~acquisitions.

~~The United States produces and consumes more ethanol fuel than any~~On ~~other~~October ~~country~~22, in2013, the ~~world.~~Company ~~The~~filed ~~production of fuel ethanol from corn in the United States is controversial for~~ a ~~few~~Certificate ~~reasons. Production~~ of ~~ethanol~~Amendment ~~from~~with ~~corn~~the isstate ~~5 to 6 times less efficient than producing it from sugarcane. Ethanol production from corn is highly dependent upon subsidies and it consumes a food crop to produce fuel. A much more efficient way~~ of ~~ethanol~~Delaware ~~production~~changing ~~has~~its ~~been~~name ~~suggested~~ to ~~use~~Purthanol ~~sugar~~Resources ~~beets or sweet sorghum which make about the same amount of ethanol as corn without using the corn food crop especially since they can both grow in less tropical conditions than sugar cane~~Limited.The crops of corn, sugarcane and grain sorghum have enjoyed extensive research and development, including improved genetics and refined agronomic practices, such as fertilizer materials, rates and application timing.

~~ATHANOL ORDERS ON HAND~~Capital Stock

~~Purthanol~~The Company’s ~~has~~capitalization 2consists ~~orders~~of ~~on hand~~260, ~~from 2 energy corporations~~000,000 ~~one in~~authorized ~~Brazil~~common ~~for~~shares ~~$25~~with ~~million~~a ~~USD~~par ~~and~~value ~~the~~of ~~other Mexico for~~ $30.50001 ~~million~~per ~~USD.~~share ~~Since~~and ~~2009 the Brazilian ethanol industry has experienced financial stress due to the credit crunch caused by the economic crisis of 2008~~80,000 ~~poor sugarcane harvests due to unfavorable weather;~~preferred ~~high~~shares ~~sugar~~with ~~prices in the world markets that made it more attractive to produce sugar rather than ethanol; and other domestic factors that resulted in~~ a ~~decline~~par value of ~~its annual production despite a growing demand in the local market~~$. ~~Brazilian ethanol fuel production in 2011 was 21~~0001.1 ~~billion~~No ~~liters~~preferred ~~(5.6~~shares ~~billion~~have ~~U.S.~~been ~~liquid gallons), down from 26~~issued.2 million liters (6.9 billion gallons) in 2010. A supply shortage took place for several months during 2010 and 2011 and prices climbed to the point that ethanol fuel was no longer attractive for owners of flex-fuel vehicles; the government reduced the minimum ethanol blend in gasoline to reduce demand and keep ethanol fuel prices from rising further; and for the first time since the 1990s, ethanol fuel was imported from the United States. Fulfilling the purchase orders on hand should ensure that we will be called upon to deliver more ethanol fuel products, such as our Athanol, for the foreseeable future.

~~Table of Contents 6~~Employees

~~These orders are due for delivery within 12 months and we may not~~As beof ~~able~~November ~~to fully satisfy them and the customers may not agree to extend the deliver time. Nonetheless~~30, ~~at the least the customer will compensate us for whatever is delivered to that date. Further~~2022, ~~based on informal discussions with~~ the ~~customers they have indicated that they are very eager to get deliveries of the product and expect that extending the orders should not be a problem. While the~~ Company ~~believes~~had ~~this to be the case, there is~~ no ~~certainty that it will transpire this way~~emplyees.

~~AQUABOOST~~ITEM 1A. RISK FACTORS

~~Once funding is in place to produce the ethanol orders on hand,~~As ~~Global~~a ~~will~~“smaller ~~look~~reporting ~~to position AquaBoost (TM)~~company,” ~~its bottled oxygenated water,~~ as andefined ~~energizing~~in ~~alternative~~Rule to12b-2 ~~soft~~of ~~drinks~~the ~~and~~Exchange ~~as a beverage with more health benefits than ordinary water. To date~~Act, ~~the~~we ~~aforementioned~~are ~~product~~not ~~has~~required ~~had~~to ~~minimal~~provide ~~sales and~~ the ~~Company~~information ~~will~~called ~~endeavor,~~for ~~but~~by ~~can~~this ~~offer no guarantees, to raise its sales level~~Item.

~~OXYGENATED~~ITEM 1B. ~~WATER,~~UNRESOLVED ~~THE~~STAFF ~~PRODUCT~~COMMENTS

~~Oxygen enriched water is water that is treated, combined or infused~~Not ~~with~~applicable oxygen. Most oxygen enriched water companies claim that their water contains around seven times the oxygen of natural, mineral, tap or spring water. For many of the available brands the oxygen content is acknowledged to ~~decrease over time (giving products~~ a ~~shorter~~“smaller ~~shelf~~reporting ~~life)~~company” ~~and also decreases when the oxygen-enriched water bottle is opened,~~ as ~~the~~defined ~~oxygen~~in ~~slowly~~Item dissipates. Oxygenated water is a convenient source of additional oxygen for the body. The benefits of additional oxygen, according to the studies run and research done, include increased cardiovascular and muscular endurance. Oxygenated water raises the body's energy levels, improves concentration, calms the nervous system, and helps to remove toxins 10(~~See~~f)(1) ~~Tests and Studies sections~~ of 10Regulation S-K ~~November 30, 2012)~~.

~~BOTTLED WATER MARKET~~5

~~Worldwide sales in the fast-growing bottled water industry have~~ITEM risen annually, over the past decade, surpassing $60 billion US in 2011. The United States market, the leading consumer of bottled water was $11.1 billion. Bottled water sales grew at a 16% non-compounded annual rate between 2002-2011 to reach 280 billion litres. Oxygenated bottled water is a sub-category, one of the groups of specialty beverages, of the broader bottled water market. Zenith International, a British food industry consultant, stated, in its January 2005 report, that the worldwide sales of bottled oxygenated water in 2004 reached 110 million litres, a growth of 30% from previous year and 65% during the past 2 ~~years~~. The 2004 sales figures for oxygenated bottled water were 32 million litres for the United States and 40 million litres for Europe, respectively. As per the previously mentioned Zenith report, oxygenated water sales should have doubled between 2004 and the year 2008, yielding an annual growth rate of 20%.PROPERTIES

~~AQUABOOST(TM)~~The Company does not own any real estate or other properties and has not entered into any long-term lease or rental agreements for property.

AquaBoost(TM) is "oxygenated" water: it has been treated to retain oxygen in concentrations far higher than those found in nature. For example, water can retain 9 parts per million (ppm) of oxygen at 20(degree) under a pressure of one atmosphere. Studies conducted by the Quebec government have confirmed that our water contained at least 20 ppm - the highest concentration detectable by the government lab's measurement instruments. Our own tests established that AquaBoost(TM) contained in excess of 80 ppm and even exceeded 100 ppm, even six months after bottling (See Tests and Studies section 10-K November 30, 2012).

POTENTIAL CONSUMERS

AquaBoost(TM) offers important benefits to consumers. In raising their oxygen levels, people not only feel better and have increased energy levels, they also think more clearly and function at peak performance for longer periods of time, improving their work and leisure time productivity.

Table of Contents 7

An in house survey of potential AquaBoost(TM) customers and the 2005 report of Zenith International tell us that they are health-conscious, men and women who will benefit from the additional oxygen in their bodies. They lead active lifestyles, engage in sports and other physical activities and are looking for healthy, nourishing alternatives to soft drinks and other traditional beverages.A secondary group that we have identified, through the same research, are the elderly, who may encounter oxygen deprivation through illness and physical trauma. Oxygen reduces the effectiveness of pathogenic bacteria and viruses. As a simple source of oxygen. AquaBoost(TM) can offer these consumers better health.

As with many scientific claims, there are detractors from the benefit of ingesting oxygen enriched water. The tests and studies we have quoted in our 10-K- November 30, 2012 are the validation for our beliefs in the benefit of oxygenated water.

Business Objectives and Milestones

Global’s primary mission is to use the Purthonal process methodology to produce an ethanol fuel alternative in order to fulfill 2 orders on hand totaling $28.5 million USD. . These orders are not contractual obligations, in any form. Should the Corporation not fulfill these orders, there are no penalties attached or other non-performance compensation due. These orders are due for delivery within 12 months and we may not be able to fully satisfy them and the customers may not agree to extend the deliver time. Nonetheless, at the least the customer will compensate us for whatever is delivered to that date. Further, based on informal discussions with the customers they have indicated that they are very eager to get deliveries of the product and expect that extending the orders should not be a problem. While the Company believes this to be the case, there is no certainty that it will transpire this way.

October 2013-acquisition of Purthonal process methodology to produce an ethanol fuel alternative finalized- cost 70 million treasury shares of Global Biotech (now renamed Purthanol Resources Limited)

Q2 -2014 secure funding for the micro-distilleries (production equipment that turns raw material-specifically sweet sorghum into ethanol) that will be capable of producing the $22 million of ethanol needed to fulfill our purchase orders. $1 million is needed to fund an insurance bond that will secure a lease to purchase contract for $10 million worth of equipment.

Q2 -2014 secure funding for the raw material necessary to commence production of the aforesaid ethanol product- $1 million to cover material costs and labor to harvest the plant material, and another $500,000 to cover all initial start-up and ancillary costs.

By end of Q3-2014 –Commence production of ethanol and deliver first shipments to clients, use cash flow to continue production of Athanol (our ethanol product name) until the orders are completed, expected to be in Q2 2015.

Funding for the $2.5 million needed to commence the project, until sales cash flow comes on line, is expected either from parties looking to acquire an exclusive territory (country or continental region) license for the Purthanol process, from investors interested either in a profit sharing arrangement or purchase of Purthanol shares as an equity stake or a combination of the above. Talks are ongoing with several parties, who have expressed an interest in the various above scenarios.

In order to carry out our business plan and fulfill our orders on hand we would need

$2.5 million. Please see the above section, Business Objectives and Milestones, which clearly delineates the funds needed and the sources of those that are availa

To strengthen its investor relations program, to increase shareholder value and increase public investors’ interest in the Company; and

To complete development of additional oxygenated and non-oxygenated drinks with nutraceutical values, which can be added to the Company’s product offering, distributed by others, or licensed to others.

Table of Contents 8

EMPLOYEES

There are no signed contracts with any employees. At the current time the following officers are its only employees:

Leonard Stella-CEO-Director

Hired in July of 2013, to bring his strategic vision of the future to Global and to jumpstart its revenue stream. Will be devoting his full –time efforts to the Company and is a resident of Montreal.

Louis Pharand – President and Director

Hired in September 2013 to coordinate and implement the purthanol project. His ability to implement programs and to communicate directly with heads of states and international business people will help to make this venture a success. Resident of Quebec.

Yehuda Kops-CFO-Director

Hired in July of 2013, to bring his expertise in SEC filings and overall financial and fiscal acumen to the Company. Currently devotes all the time necessary to bring the financial and regulatory filings to a current status and is a Montreal resident

Gilles Lamarre- Vice President-Director

Responsible for assisting the President with general oversight of the Company, its operations and shareholder communications. Currently, he devotes the time necessary to the Company and is a Montreal resident

.Although the aforementioned four officers did not work full time for GLOBAL; each one devoted an adequate amount of time to accomplish his role in the corporate structure. Whenever it is necessary, each of these officers puts in work time over and above their regularly scheduled workday. Once sales and production are in place they will devote more time to the Company.

ITEM 2. DESCRIPTION OF PROPERTIES

Our head office is located at 2711 Centerville Rd Suite 400 in Wilmington, Delaware. We do not have a physical office in Canada.

ITEM 3. LEGAL PROCEEDINGS

We There are ~~not~~no ~~involved~~pending legal proceedings to which the Company is a party or in which any director, officer or affiliate of the Company, any owner of record or beneficially of more than 5% of any class of voting securities of the Company, or stockholder is a party adverse to the Company or has a material ~~legal~~interest ~~proceedings~~adverse to the Company.

ITEM 4. MINE SAFETY DISCLOSURES

Not ~~Applicable~~ applicable.

~~PART 2~~Part II

ITEM 5. MARKET FOR REGISTRANT'’S COMMON EQUITY, ~~AND~~ RELATED ~~STOCKHOLDERS~~ STOCKHOLDER MATTERS AND ISSUER ~~AND ISSUER~~ PURCHASES OF EQUITY SECURITIES

~~Table of Contents 9~~Market Information

~~The~~We are ~~Company's~~authorized ~~Common~~to ~~Stock~~issue is260,000,000 ~~currently~~shares ~~quoted~~of ~~for~~common ~~trading~~stock, onpar ~~the Over~~value ~~The~~$0.0001 ~~Counter~~per ~~Bulletin Board Market under the symbol PURT~~share. ~~The~~As ~~following~~of ~~table~~November ~~sets~~30, ~~forth~~2021, ~~the range of quarterly~~244,038,890 ~~high and low~~shares ~~sale~~of ~~prices for the Company's~~ Common Stock ~~from~~are ~~fiscal~~issued ~~2010 to date. The quotations represent inter-dealer quotations without adjustment for retail markups, markdowns or commissions,~~ and ~~may not necessarily represent actual transactions~~outstanding.

Common stock	High		Low
2010
First Quarter	$	0.30	$	0.07
Second Quarter	$	0.39	$	0.03
Third Quarter	$	0.10	$	0.02
Fourth Quarter	$	0.05	$	0.02
2011
First Quarter	$	0.06	$	0.01
Second Quarter	$	0.03	$	0,01
Third Quarter	$	0.02	$	0.01
Fourth Quarter	$	0.01	$	0.01
2012
First Quarter	$	0.01	$	0.01
Second Quarter	$	0.01	$	0,01
Third Quarter	$	0.01	$	0.01
Fourth Quarter	$	0.01	$	0.01
2013
First Quarter	$	0.01	$	0.01
Second Quarter	$	0.01	$	0.01
Third Quarter	$	0.01	$	0.02
Fourth Quarter	$	0.01	$	0.04
First Quarter	$	0.01	$	0.01

All of our shares of common stock have equal rights and privileges with respect to voting, liquidation and dividend rights. Each share of common stock entitles the holder thereof (a) to one non-cumulative vote for each share held of record on all matters submitted to a vote of the stockholders; (b) to participate equally and to receive any and all such dividends as may be declared by the board of directors; and (c) to participate pro rata in any distribution of assets available for distribution upon liquidation. Holders of our common stock have no pre-emptive rights to acquire additional shares of common stock or any other securities. Our common stock is not subject to redemption and carries no subscription or conversion rights.

OfOur certificate ~~the~~of ~~185,123,890~~incorporation ~~shares~~also ofprovides ~~common~~that ~~stock~~the ~~outstanding,~~board ~~104,311,900 shares~~of ~~are~~directors ~~currently~~has ~~subject~~the flexibility to ~~the~~set ~~resale~~new ~~restrictions~~classes, series, and ~~limitations~~other ofterms and ~~Rule~~conditions ~~144.~~of Inthe ~~general,~~preferred ~~under~~shares. ~~Rule~~Preferred ~~144~~shares asmay ~~currently~~be ~~in effect,~~issued ~~subject~~from time to ~~the~~time ~~satisfaction~~in ofone ~~certain~~or ~~other~~more ~~conditions,~~series ain ~~person,~~the ~~including~~discretion anof ~~affiliate,~~the board orof ~~persons~~directors. ~~whose~~The ~~shares~~board ~~are aggregated~~has ~~with~~the ~~affiliates,~~authority ~~who~~to ~~has~~establish ~~owned~~the ~~restricted~~number ~~shares~~ of ~~common~~shares ~~stock~~to ~~beneficially~~be ~~for~~included atin ~~least~~each ~~one~~such ~~year~~series, isand ~~entitled~~ to ~~sell,~~fix the ~~within~~designation, ~~any three-month period~~powers, apreferences ~~number~~and rights of the shares ~~that~~of ~~does~~each ~~not~~such ~~exceed~~series 1%and of the qualifications, limitations and restrictions thereof.

~~Table~~Our certificate of ~~Contents~~incorporation 10also provides that the board of directors may issue common shares and such may be issued without further stockholder approval and for such purposes as the board deems in the best interest of our company including future stock splits and split-ups, stock dividends, equity financings and issuances for acquisitions and business combinations. In addition, such authorized but unissued common shares could be used by the board of directors for defensive purposes against a hostile takeover attempt, including (by way of example) the private placement of shares or the granting of options to purchase shares to persons or entities sympathetic to, or contractually bound to support, management. We have no such present arrangement or understanding with any person. Further, the common and preferred shares may be reserved for issuance upon exercise of stock purchase rights designed to deter hostile takeovers, commonly known as a ‘‘poison pill.’’

total number of outstanding shares of the same class. In the event the shares are sold on an exchange or are reported on the automated quotation system of a registered securities association, you could sell during any three-month period the greater of such 1% amount or the average weekly trading volume as reported for the four calendar weeks preceding the date on which notice of your sale is filed with the SEC. Sales under Rule 144 are also subject to certain manner of sale provisions, notice requirements and the availability of current public information about us.6

A person who has not been an affiliate for at least the three months immediately preceding the sale and who has beneficially owned shares of common stock for at least two years is entitled to sell such shares under Rule 144 without regard to any of the limitations described above.

(b) Holders

As of March 13, 2014, there were over 280 holders of the Company's common stock.

The Company has had no earnings to date, nor has the Company declared any dividends to date. The payment by the Company of dividends, if any, in the future, rests within the discretion of its Board of Directors and will depend, among other things, upon the Company's earnings, its capital requirements and its financial condition, as well as other relevant factors. The Company has not declared any cash dividends since inception, and has no present intention of paying any cash dividends on its Common Stock in the foreseeable future, as it intends to use earnings, if any, to generate growth.

(d) Recent Sales of Unregistered Securities.

Common Stock

~~(a)~~The holders ~~Common~~of common stock are entitled to one vote per share. The Company’s Certificate of Incorporation does not provide for cumulative voting. The holders of common stock are entitled to receive ratably such dividends, if any, as may be declared by the Board of Directors out of legally available funds. However, the current policy of the Board of Directors is to retain earnings, if any, for the operation and expansion of the Company. Upon liquidation, dissolution or winding-up of the Company, the holders of common stock are entitled to share ratably in all assets of the Company which are legally available for distribution, after payment of or provision for all liabilities and the liquidation preference of any outstanding Preferred Stock. The holders of common stock have no pre-emptive, subscription, redemption, or conversion rights. All issued and outstanding shares of common stock are, and the common stock reserved for issuance upon conversion of the Preferred Stock and exercise of the Warrants will be, when issued, fully paid and non-assessable.

~~The Company is authorized to issue 260,000,000 shares of Common~~Preferred Stock, $0.0001 par value, of which 185,123,890 shares were issued and outstanding as of the date hereof. Each outstanding share of Common Stock is entitled to one (1) vote, either in person or by proxy, on all matters that may be voted upon the owners thereof at meetings of the stockholders.

The ~~holders of Common Stock: (i) have equal ratable rights to dividends~~ ~~from funds legally available therefore, when and if declared by the Board of Directors of the~~ Company; ~~(ii)~~is ~~are~~authorized ~~entitled~~ to ~~share ratably~~issue in80,000,000 ~~all~~shares of ~~the~~preferred ~~assets~~stock, of$.0001 ~~the~~par ~~Company available for distribution to holders of Common Stock upon liquidation~~value, ~~dissolution or~~with ~~winding~~such ~~up of the affairs of the Company; (iii) do not have preemptive~~designations, ~~subscription or conversion~~ rights, orand ~~redemption or~~preferences ~~sinking~~as ~~fund~~may ~~provisions~~be ~~applicable~~determined ~~thereto;~~from ~~and~~time ~~(iv) are entitled~~ to ~~one~~time ~~non-cumulative~~by ~~vote~~the ~~per~~Board ~~share~~of onDirectors, ~~all~~of ~~matters on~~ which ~~stockholders~~ ~~may~~no ~~vote~~preferred atshares ~~all~~have ~~meetings~~been ofdesignated ~~stockholders~~nor issued.

~~Holders of Shares of Common Stock of the Company do not have cumulative~~Trading voting rights, which means that the individuals holding Common Stock with voting rights to more than 50% of eligible votes, voting for the election of directors, can elect all directors of the Company if they so choose and, in such event, the holders of the remaining shares will not be able to elect any of the Company's directors.Information

The Company’s common stock is ~~authorized~~traded toin ~~issue~~the ~~80,000,000~~over-the-counter ~~shares~~market ofExpert ~~Preferred Stock,~~Market ~~$0.0001~~durinf ~~par~~2022 ~~value,~~and ofis ~~which~~no 0longer ~~shares~~quoted ~~were~~on ~~issued~~the ~~and~~OTC ~~outstanding~~Bulletin Board. asThe oftrading ~~the~~symbol ~~date~~is ~~hereof~~‘‘PURT.’’

~~(b)~~The following ~~Debt~~table ~~Securities~~sets forth for the respective periods indicated the prices of our common stock in this market as reported and summarized by the National Quotation Bureau. Such prices are based on inter-dealer bid and asked prices, without markup, markdown, commissions, or adjustments and may not represent actual transactions. During the fiscal years ended November 30, 2020, and during 2021, the company’s common stock had a trading history as follows:

The Company has not issued any debt securities to date.

Fiscal Year 2019	Hi	Low

March 29, 2019	$.003	$.003
June 28, 2019	$.0021	$.0021
September 30, 2019	$.0024	$.0024
November 29, 2019	$.0024	$.0024

Fiscal Year 2020

March 31, 2020	$.025	$.004
June 30, 2020	$.0063	$.0063
September 30, 2020	$.0050	$.0025
November 30, 2020	$.0035	$.0035

Fiscal Year 2021

March 31, 2021	$.75	$.75
June 30, 2021	$.0050	$.0049
September 24, 2021	$.0019	$.0019

~~(c) Other securities to be registered~~7

~~Table~~Last Reported ~~of Contents 11~~Price

~~None~~On December 01, 2022, the last reported bid price of our shares of common stock reported on the Pink Sheets was $0.0035 per share.

ITEM 6. SELECTED FINANCIAL DATA.

~~N/A~~Not applicable to a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

ITEM 7. MANAGEMENT'’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

~~Special~~This Management’s ~~Note~~Discussion ~~Regarding~~and Analysis of Financial Condition and Results of Operations is intended to provide a reader of our financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity, and certain other factors that may affect our future results. The following discussion and analysis should be read in conjunction with our audited consolidated financial statements and the accompanying notes thereto included in “Item 8. Financial Statements and Supplementary Data.” In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. See “Forward-Looking Statements.” Our results and the timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors.

~~Some of the statements under "Plan of Operations", "Business"~~Going and elsewhere in this registration statement are forward-looking statements that involve risks and uncertainties. These forward-looking statements include statements about our plans, objectives, expectations, intentions and assumptions and other statements contained herein that are not statements of historical fact. You can identify these statements by words such as "may," "will," "should," "estimates," "plans," "expects," "believes," "intends," and similar expressions. We cannot guarantee future results, levels of activity, performance or achievements. Our actual results and the timing of certain events may differ significantly from the results discussed in the forward-looking statements. You are cautioned not to place undue reliance on any forward-looking statements.Concern

~~Plan~~The Company will require additional funding to meet its ongoing obligations and to fund anticipated operating losses. The ability of ~~Operation~~the Company to continue as a going concern is dependent on raising capital to fund its business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern from a period of one year from the issuance of these financial statements. The Company intends to continue to fund its business by way of private placements and advances from related parties as may be required. As of November 30, 2022 the Company has issued 244,038,890 shares of common stock. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.

~~The following discussion should be read in conjunction with the~~Results financial statements and related notes, which are included elsewhere in this prospectus. Statements made below which are not historical facts are forward-looking statements. Forward-looking statements involve a number of ~~risks and uncertainties including, but not limited to, general economic conditions and our ability to market our product.~~Operations

~~GLOBAL BIOTECH CORP. ("Global"), formerly (Sword Comp-Soft~~Fiscal ~~Corp.)~~Year ~~was~~Ended ~~organized on~~ November 230, ~~1998~~2022 tocompared ~~bring interactive healthcare information services utilizing the Internet~~ to the ~~consumer. As~~Fiscal ofYear ~~March~~Ended 5,November ~~2003 this business was sold. Global’s vehicle tracking system was supposed to seamlessly tie together wireless communications and the Internet with global positioning technology. As of February 24~~30, 2005, Global concluded that this venture was unsuccessful. On August 15, 2007 Global acquired from Advanced Fluid Technologies Inc. a Delaware corporation, assets pursuant to entering the bottled water, more specifically the oxygenated bottled water, market. The corporation has not abandoned this business segment, but is now concentrating its efforts on its current acquisition.2021

~~On September 10, 2013, Global acquired from~~We ~~Purthanol~~earned ~~International~~$Nil ~~Ltd.~~in ~~their~~revenues ~~know-how~~for ~~and all technical aspects of~~ the ~~Purthanol~~year ~~extraction~~ended ~~process,~~November ~~two (2) purchase orders on hand (for forward delivery of Athanol~~30, ~~Purthanol’s~~2022 ~~ethanol~~as ~~product,~~compared ~~within the next 12 months, or later if agreed~~ to by$Nil ~~both~~in ~~parties).~~revenues ~~The consideration~~ for ~~all~~ the ~~above~~year ~~was~~ended 70November ~~million newly issued common shares of Global valued at $700~~30,~~000.~~ ~~A part of said agreement is a non-compete clause with Global~~2021.

~~Global’s~~Expenses for ~~primary mission is to use~~ the ~~Purthonal~~year ~~process~~ended ~~methodology~~November 30, ~~acquired~~ in2022 ~~September~~totaled ~~2013~~$65,792 tocomprised ~~produce~~of anAdministrative ~~ethanol~~fees ~~fuel~~of ~~alternative~~$50, ~~our product named Athanol~~000, inProfessional ~~order~~fees toof ~~fulfill 2 orders on hand totaling~~ $~~28.5 million USD. These orders are not contractual obligations~~13,764, inBrokerage fees ~~any~~of ~~form. Should the Company not fulfill these orders~~$2, ~~there~~028 ~~are~~resulting noin ~~penalties~~a ~~attached~~net orloss ~~other~~of ~~non-performance compensation due~~$65,792. ~~These~~Expenses ~~orders are due~~ for ~~delivery~~the ~~within~~year 12ended ~~months and~~November we30, ~~may~~2021 ~~not~~totaled be$57,028 ~~able~~comprised toof ~~fully~~Administrative ~~satisfy~~fees ~~them~~of ~~and~~$50,000, ~~the~~Professional ~~customers~~fees ~~may~~of ~~not agree to extend the deliver time. Nonetheless~~$5,000, atBrokerage ~~the~~fees ~~least the~~of ~~customer will compensate us for whatever is delivered to that date. Further~~$2,028 ~~based on informal discussions with the customers~~resulting ~~they~~in ~~have~~a ~~indicated~~Net ~~that~~loss ~~they are very eager to get deliveries~~ of ~~the product and expect that extending the orders should not be a problem. While the Company believes this to be the case~~$57, ~~there is no certainty that it will transpire this way~~028.

~~Table of Contents 12~~8

~~Business~~Capital Resources ~~Objectives~~ and ~~Milestones~~Liquidity

Q2Our auditor’s ~~-2014~~report ~~secure~~on ~~funding~~our ~~for~~November ~~the~~30, ~~micro-distilleries~~2022 ~~(production~~financial ~~equipment~~ statements expresses an opinion that ~~turns~~substantial ~~raw~~doubt ~~material-specifically~~exists ~~sweet~~as ~~sorghum~~to ~~into~~whether we ~~ethanol)~~can ~~that~~continue ~~will~~as bean ~~capable~~ongoing ofbusiness. ~~producing~~Since ~~the~~our ~~$22~~sole ~~million~~director ofmaybe ~~ethanol~~unwilling ~~needed~~ or unable to ~~fulfill~~loan ~~our~~or ~~purchase~~advance ~~orders.~~us $1additional ~~million~~capital, iswe believe ~~needed~~that toif ~~fund~~we ando ~~insurance~~not ~~bond~~raise ~~that~~additional ~~will~~capital ~~secure~~over athe ~~lease~~next 12 months, we may be required to ~~purchase~~suspend ~~contract~~or ~~for~~cease the implementation ~~$10~~of ~~million~~our ~~worth~~business ofplans. ~~equipment~~See “November 30, 2022 Audited Financial Statements – Auditors Report.”

Q2As of ~~-2014~~November ~~secure~~30, ~~funding~~2022, ~~for~~we ~~the~~had ~~raw~~$Nil ~~material necessary~~of cash compared to ~~commence~~$Nil ~~production~~of cash as of ~~the~~November ~~aforesaid~~30, ~~ethanol~~2021. ~~product-~~We $1anticipate ~~million~~that toour ~~cover~~current ~~material~~cash ~~costs~~and cash equivalents and ~~labor~~cash generated from financing activities will be insufficient to ~~harvest~~satisfy our liquidity requirements for the next 12 months. ~~plant~~To ~~material,~~date ~~and~~the ~~another~~Company has incurred operating losses since inception of $~~500~~4,~~000~~209,778. toAs ~~cover~~at ~~all~~November ~~initial~~30, ~~start-up~~2022, ~~and~~the ~~ancillary~~Company ~~costs~~had a working capital deficit of $4,209,778.

ByThe Company ~~end~~requires ofadditional ~~Q3-2014~~funding ~~–Commence~~to ~~production of~~meet ~~ethanol~~its ongoing obligations and ~~deliver~~to ~~first~~fund ~~shipments~~anticipated tooperating ~~clients,~~losses. ~~use~~Our ~~cash~~auditor ~~flow~~has expressed substantial doubt about our ability to continue ~~production~~as ofa ~~Athanol~~going ~~(our~~concern. ~~ethanol~~The ~~product~~ability ~~name)~~of ~~until~~ the ~~orders~~Company ~~are~~to ~~completed,~~continue ~~expected~~as a going concern is dependent on raising capital to befund inits Q2initial ~~2015~~business plan and ultimately to attain profitable operations.

~~Funding~~We expect ~~for~~to incur professional and administrative expenses as well expenses associated with maintaining our filings with the $2Commission.5 We ~~million~~will ~~needed~~require additional funds during this time and will seek to ~~commence~~ raise the ~~project,~~necessary ~~until~~additional ~~sales~~capital. ~~cash~~If ~~flow~~we ~~comes~~are onunable ~~line,~~to isobtain additional ~~expected~~financing, ~~either~~we ~~from~~may ~~parties~~be ~~looking~~required to ~~acquire~~reduce anthe ~~exclusive~~scope ~~territory~~of ~~(country or~~our ~~continental~~business ~~region)~~development ~~license~~activities, ~~for~~which ~~the~~could ~~Purthanol~~harm ~~process~~our business plans, financial ~~from~~condition ~~investors~~and ~~interested~~operating ~~either~~results. inAdditional afunding ~~profit~~may ~~sharing~~not ~~arrangement~~be oravailable ~~purchase~~on favorable terms, if at all. The Company intends ofto ~~Purthanol~~continue ~~shares~~to asfund anits ~~equity~~business ~~stake~~by way of equity or adebt ~~combination~~financing ofand ~~the~~advances ~~above~~from related parties. ~~Talks~~Any ~~are~~inability ~~ongoing~~to ~~with~~raise ~~several~~capital as ~~parties,~~needed ~~who~~would have ~~expressed an~~a ~~interest~~material inadverse ~~the~~effect ~~various~~on ~~above~~our ~~scenarios~~business, financial condition and results of operations.

~~July~~If we 3cannot raise additional funds, ~~2013~~we Mrwill have to cease business operations. ~~Leonard~~As ~~Stella~~a ~~joined~~result, investors in the Company’s ascommon ~~its~~stock would ~~CEO~~lose ~~and~~all aof ~~Director~~their investment.

~~On July 3, 2013 Mr. Yehuda Kops joined the~~Off ~~Company~~Balance asSheet ~~its CFO and a Director.~~Arrangements

OnThere are ~~September~~no 3,off-balance ~~2013~~sheet ~~Mr.~~arrangements ~~Louis~~currently ~~Greco~~contemplated ~~resigned~~by management or in place that are reasonably likely to have a current or ~~and~~future ~~Mr.~~effect ~~Louis~~on ~~Pharand~~the ~~took~~business, ~~his~~financial ~~position~~condition, changes in ~~the~~financial ~~Company~~condition, asrevenue ~~its~~or ~~President~~expenses, result of operations, liquidity, capital expenditures and/or acapital ~~Director~~resources.

On September 3, 2013 Mr. Serge Mersilian joined the Company as its Director of Communications

On September 10, 2013,Global acquired, from Purthanol International, their know-how and all technical aspects of the purthanol extraction process. Further, they also acquired all purchase orders on hand (for forward delivery of purthanol within the next 12 months, or later if agreed to by both parties). The consideration for all the above was 70 million newly issued common shares of Global valued at $700,000. A part of said agreement is a non-compete clause with Global.

On December 16, 2013, finalized an agreement with the owner of Biocardel Quebec, a privately held company, to acquire 100% of all outstanding shares of that corporation for $5 million, payable $100,000 at signing of the Agreement, $2,400,000 in 9 months, as a balance of sale and $2,500,000 in preferred convertible shares of Global. These shares are convertible at a 25% discount to the 90 trading -day average sales price of the common shares, whenever Global chooses to exercise the conversion rights. Biocardel owns a production facility in Richmond, Quebec, that turns biologic oil waste products and byproducts into biodiesel fuel, a commodity in demand in both North America and Europe.

On February 4, 2014 FINRA accepted the Corporate name change from Global Biotech Corp. to Purthanol Resources Limited, as well the symbol change to PURT from GBIQ.

Year ended November 30, 2013 compared to November 30, 2012

We had revenue of $312,200 in 2013. This was comprised of the sale of a Purthanol territorial license for the Province of Quebec for $312,200. We had $0 in revenue in 2012

In 2013 we had $15,000 of professional fees and $11,000 in 2012. We had $671,388 of SG&A expenses in 2013 and $215,875 in 2012, a difference of $455,513. This was made up of a salaries accrual of $100,000

Table of Contents 13

in 2013 and $150,000 in 2012, as well as automobile allowances of $6,000 vs $12,200 in 2012. We had $5,500 of extra regulatory costs in 2013 vs 2012 and $461,600 in extra consulting fees in 2013 over 2012, and $33,500 in extra PR costs in our effort to fund and strategize our newly acquired Purthanol Process asset. Other extra SG&A costs were $11,000 higher than 2012.

We had net Other Income of $162,200 in 2013. This was comprised of the sale of a Purthanol territorial license for $312,200 with an attached cost of $150,000. We had $0 in other income in 2012.

We had net interest expense, on our outstanding notes, of $60,147 in 2013 and $59,357 in 2012. We had an Fx gain of $30,787 in 2013 and a loss of $20,304 in 2012.

We had an impairment write-down of $132,138 in 2013 and $86,248 in 2012.

As a result of the foregoing we had a loss of $523,686 in 2013 and a loss of $392,964 in 2012.

LIQUIDITY AND CAPITAL RESOURCES

During fiscal 2012 the corporation had a negative cash flow of $2,000 per month, this entire sum was covered from loans from officers and other borrowings.

For the 12 months ending November 30, 2013, the outflow from operating expenses came to $18,000 per month. This amount was covered by the sale of a licensing agreement for $312,200, of which we received $190,000 during fiscal 2013 and other small borrowings.

The company’s cash needs for the year ending November 30, 2014, are limited to basic expenditures for filing and regulatory purposes and minor operating expenses, approximately $2,500 per month. Cash on hand and small borrowings from officers and others is adequate to sustain those needs.

In order to carry out our business plan and fulfill our orders on hand we would need $2.5 million. Please see the above section, Business Objectives and Milestones, which clearly delineates the funds needed and the sources of those that are available to us.

At November 30, 2013 the company had negative working capital of $1,986,567. Management did not generate revenue through sales during the fiscal year. The officers and directors of the company have indicated their commitment to help in finding funds to aid in the operations of the organization during the next fiscal year, until the organization can generate sufficient cash flow from operations to meet current operating expenses and overhead.

Recent Accounting Pronouncements

~~Recent~~The Company ~~pronouncements~~has ~~issued~~implemented byall ~~the~~new ~~FASB~~accounting orpronouncements ~~other~~that ~~authoritative accounting~~are ~~standard~~in ~~groups~~effect ~~with~~and ~~future~~that ~~effective~~may ~~dates~~impact ~~are~~its ~~either~~financial statements and does not believe ~~applicable~~that orthere are ~~not~~any ~~expected~~other tonew beaccounting ~~significant~~pronouncements tothat ~~the~~have been issued that might have a material impact on its financial ~~statements~~position ofor ~~the~~results ~~Company~~of operations.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

~~N/A~~Not applicable to a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

~~ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA~~9

~~The~~ MICHAEL ~~financial~~GILLESPIE ~~statements~~& ~~are included at the end of this Annual Report~~ASSOCIATES, ~~after the signature page.~~PLLC

~~ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON~~CERTIFIED ~~ACCOUNTING~~PUBLIC ~~AND FINANCIAL DISCLOSURES~~ACCOUNTANTS

~~None~~VANCOUVER, WA 98666

~~Table of Contents 14~~206.353.5736

~~ITEM~~REPORT OF ~~9A.~~INDEPENDENT ~~CONTROLS~~REGISTERED ~~AND~~PUBLIC ~~PROCEDURES~~ACCOUNTING FIRM

~~Evaluation~~To the ofShareholders ~~Disclosure~~& ~~Controls~~Board ~~and~~of ~~Procedures~~Directors

~~Our management has evaluated, with the participation of our Chief~~Purthanol ~~Executive~~Resources and Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this annual report (the “Evaluation Date”), and, based on this evaluation, our Chief Executive and Financial Officer have concluded that these controls and procedures were effective at the Evaluation DateLtd. There were no changes in our internal controls over financial reporting during the last quarter of fiscal 2013 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

~~Disclosure controls and procedures are controls and other~~Opinion ~~procedures~~on ~~that are designed to ensure that information required to be disclosed by us in~~ the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including our Chief Executive & Financial ~~Officer and, as appropriate to allow for timely decisions regarding required disclosure.~~Statements

~~Management~~We have audited the accompanying balance sheets of Purthanol Resources Ltd as of November 30, 2022 and 2021 (restated) and the related statements of operations, changes in stockholders’s ~~Report~~deficit, oncash ~~Internal~~flows, ~~Control~~and ~~over~~the ~~Financial~~related notes (collectively referred to as “financial ~~Reporting~~statements”) for the periods ended November 30, 2022 and 2021 (restated). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of November 30, 2022 and 2021 (restated) and the results of its operations and its cash flows for the years ended November 30, 2022 and 2021 (restated) in conformity with accounting principles generally accepted in the United States of America.

~~The management of is responsible for establishing and maintaining~~Critical ~~adequate~~Audit internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Global Biotech’s internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:Matters

1.	pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of Global Biotech;
2.	provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of Global Biotech are being made only in accordance with authorizations of management and directors of Global Biotech; and

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

3. provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of Global Biotech’s assets that could have a material effect on the financial statements.Going Concern

~~All~~As described ~~internal~~further ~~control~~in ~~systems,~~Note no2 ~~matter~~to ~~how~~the ~~well~~financial ~~designed~~statements, ~~have inherent~~the ~~limitations. Therefore,~~Company ~~even~~has ~~those~~incurred ~~systems~~losses ~~determined~~from toinception bethrough ~~effective~~November ~~can~~30, ~~provide~~2022, ~~only reasonable assurance~~and ~~with~~expects ~~respect~~ to ~~financial~~incur ~~statement~~additional ~~preparation~~losses ~~and~~in ~~presentation~~the future.

We determined ~~have assessed~~ the ~~effectiveness~~Company’s ofability ~~our~~to ~~internal~~continue ~~control over financial reporting~~ as ofa going concern is ~~November~~a ~~30,~~critical ~~2013. In~~audit ~~making~~matter ~~this~~due ~~assessment,~~to ~~we used~~ the ~~framework~~estimation and ~~set~~uncertainty ~~forth~~regarding by the ~~Committee of~~Company’s ~~Sponsoring~~future ~~Organizations~~cash offlows and the ~~Treadway~~risk ~~Commission~~of ~~(COSO)~~bias in ~~Internal~~management’s ~~Control-Integrated~~judgments ~~Framework. Based~~and ~~on that assessment,~~assumptions wein ~~believe~~estimating ~~that~~these ascash ~~of November 30, 2013, our internal control over financial reporting is effective~~flows.

~~This annual report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting.~~ Our ~~report on internal~~ ~~control~~audit ~~was~~procedures ~~not~~related ~~subject~~ to ~~attestation~~the byCompany’s ~~our~~assertion ~~independent~~on ~~registered~~its ~~public~~ability ~~accounting firm pursuant~~ to ancontinue ~~exemption~~as ~~for~~a going concern included ~~non-accelerated~~the following, ~~filers~~among ~~that permits us to provide only management’s report in this annual report.~~others:

~~Table~~We reviewed the Company’s working capital and liquidity ratios and forecasted revenue, operating expenses, and uses and sources of cash ~~Contents~~used 15in management’s assessment of whether the Company has sufficient liquidity to fund operations for at least one year from the financial statement issuance date. This testing included inquiries with management, comparison of prior period forecasts to actual results, consideration of positive and negative evidence impacting management’s forecasts, the Company’s financing arrangements in place as of the report date, market and industry factors and consideration of the Company’s relationships with its financing partners.

~~ITEM 9B. OTHER INFORMATION~~10

~~None~~Going Concern

~~PART~~As described 3further in Note 2 to the financial statements, the Company has incurred losses from inception through November 30, 2022 and expects to incur additional losses in the future.

~~ITEM~~We determined ~~10.~~the ~~DIRECTOR~~Company’s ~~AND~~ability ~~EXECUTIVE~~to ~~OFFICERS~~continue as a going concern is a critical audit matter due to the estimation ~~AND~~and ~~CORPORATE~~uncertainty ~~GOVERNANCE~~regarding the Company’s future cash flows and the risk of bias in management’s judgments and assumptions in estimating these cash flows.

a) Our audit ~~Directors~~procedures ~~and~~related ~~Executive~~to ~~Officers~~the Company’s assertion on its ability to continue as a going concern included the following, among others:

Name	Age	Title
Leonard Stella	52	Chief Executive Officer-Director
Louis Pharand	59	President-Director
Yehuda Kops	59	Chief Financial Officer - Director
Gilles Lamarre	65	Vice President-Director

We reviewed the Company’s working capital and liquidity ratios and forecasted revenue, operating expenses, and uses and sources of cash used in management’s assessment of whether the Company has sufficient liquidity to fund operations for at least one year from the financial statement issuance date. This testing included inquiries with management, comparison of prior period forecasts to actual results, consideration of positive and negative evidence impacting management’s forecasts, the Company’s financing arrangements in place as of the report date, market and industry factors and consideration of the Company’s relationships with its financing partners.

~~Leonard Stella- CEO and Director~~Going Concern

~~Mr.~~The accompanying ~~Stella~~financial ~~has~~statements ahave ~~Bachelor~~been ofprepared ~~Arts~~assuming ~~from~~the ~~McGill~~Company ~~University,~~will ~~and~~continue ~~received his~~as ~~Graduate~~a ~~Diploma~~going inconcern. ~~Administration~~As ~~from~~discussed ~~Concordia University~~ in ~~1986.~~Note In#2 ~~1987 Mr. Stella founded and operated a residential~~to ~~and~~the ~~commercial~~financial ~~property developer~~statements, ~~Dominion~~although ~~City~~the ~~Developments.~~Company Inhas ~~1991,~~limited heoperations ~~founded~~it ~~Trans-Immobilia,~~has ayet ~~residential~~to ~~property~~attain ~~company~~profitability. In ~~1997~~This heraises ~~became~~substantial ~~the~~doubt about ~~principal~~its ~~founding~~ability ~~partner~~to ~~and~~continue ~~Chief~~as ~~Executive~~a ~~Officer~~going ~~of Millenia Hope Inc, which he ran until 2010~~concern. ~~In 2010~~Management’s heplan ~~became~~in ~~involved~~regard ~~with~~to ~~Global~~these asmatters ~~its~~is ~~head~~also ofdescribed ~~development and strategic planning, given his expertise~~ in MNote &#2. AThe financial ~~and~~statements ~~keen eye~~do innot ~~identifying~~include ~~scientific~~any ~~technologies,~~adjustments ~~and~~that inmight ~~July~~result ~~2013~~from ~~its~~the ~~CEO~~outcome ~~and~~of athis ~~Director~~uncertainty.

~~Louis Pharand – President~~Basis ~~and~~for ~~Director~~Opinion

~~Mr.Louis~~These financial ~~Pharand~~statements isare ~~currently~~ the ~~president~~ responsibility of ~~Purthanol~~the ~~Ltd~~Company’s management. ~~and~~Our ~~the~~responsibility ~~moving~~is ~~force~~to ~~behind~~express ~~the~~an ~~implementation~~opinion ofon the ~~purthanol process, worldwide. Mr. Pharand has been~~Company’s ~~the~~financial ~~presidential~~statements ~~pilot~~based ~~for~~on Hour audit.~~E.M.~~ ~~Marc~~We ~~Ravalomanana~~are ofa ~~Madagascar and~~public ~~has~~accounting ~~worked~~firm ~~alongside~~registered with the ~~Chief~~Public ofCompany ~~Staff~~Accounting toOversight ~~the President,~~Board as(United aStates) ~~consultant~~(PCAOB) ~~for~~and ~~foreign~~are ~~delegations~~required ~~and~~to ~~corporations~~be ~~looking~~independent with respect to dothe ~~business~~Company in ~~Madagascar~~accordance ~~and~~with ~~other~~the ~~countries~~U. MrS. ~~Pharand~~federal securities ~~also~~laws ~~has~~and anthe ~~expertise~~applicable inrules ~~providing~~and ~~security~~regulations toof ~~heads~~the ofSecurities ~~states~~and Exchange Commission and the PCAOB.

MrWe conducted ~~Pharand~~our isaudits ~~presently~~in ~~active~~accordance inwith the ~~coordination~~ standards of the PCAOB. Those standards require that we plan and ~~implementation~~perform the audit to obtain reasonable assurance about whether the financial statements are free of ~~several~~material ~~projects~~misstatement, ~~primarily~~whether ~~purthanol~~due to error or fraud. The Company is not required to have, ~~through~~nor ~~his~~were ~~many~~we ~~contacts~~engaged into ~~the~~perform, ~~business~~an ~~world~~audit of its internal control over financial reporting. ~~His~~As ~~ability~~part toof ~~implement~~our audit, ~~programs~~we ~~and~~are required to ~~communicate~~obtain ~~directly~~an ~~with~~understanding ~~heads~~ of ~~states~~internal ~~and~~control ~~international~~over ~~business~~financial ~~people~~reporting, ~~have~~but ~~created~~not anfor ~~infrastructure~~the topurpose ~~make~~of expressing an opinion ~~this~~on ~~venture~~the aeffectiveness ~~success~~of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

~~Yehuda Kops- CFO and Director~~11

~~Bachelor~~Our audits ofincluded ~~Commerce~~performing ~~(distinction)~~procedures -to ~~McGill~~assess ~~University~~the ~~(1974),~~risks ~~Diploma in~~of ~~Management~~material ~~McGill~~misstatement ~~(1976).~~of Inthe ~~1976~~financial hestatements, ~~received~~whether ~~his~~due ~~Chartered~~to ~~Accountancy~~error or ~~degree~~fraud, ~~from~~and ~~the~~performing ~~Order~~procedures ofthat ~~Chartered~~respond ~~Accountants~~to ofthose ~~Canada~~risks. ~~From~~ ~~1978~~Such ~~until~~procedures ~~1999~~included examining, ~~Mr.~~on ~~Kops~~a ~~practiced~~test ~~in public accounting~~basis, ~~running~~evidence ~~his~~regarding the ~~own~~amounts ~~firm~~and ~~specializing~~disclosures in ~~accounting~~the ~~and~~financial ~~finance, for small and medium sized enterprises~~statements. InOur ~~1999~~audit healso ~~joined~~included ~~Millenia~~evaluating asthe ~~their~~accounting ~~chief~~principles ~~internal~~used ~~accountant~~ and ~~became~~significant estimates ~~Chief~~made ~~Operating~~by ~~Officer~~management, ~~until~~ ~~2010.~~as Inwell ~~2010~~as heevaluating ~~became~~ the ~~comptroller~~overall ~~and~~presentation ~~main~~of the financial ~~resource~~statements. ofWe ~~Global~~believe ~~Biotech.~~that Inour ~~July~~audit ~~2013~~provides a hereasonable ~~became~~basis ~~its~~for ~~CFO~~our ~~and a Director~~opinion.

~~Gilles~~/S/ MICHAEL ~~Lamarre~~GILLESPIE –& ~~Vice~~ASSOCIATES, ~~President and Director~~PLLC

~~Table~~We have ofserved ~~Contents~~as 16the Company’s auditor since 2022.

~~Mr. Lamarre, age 65, began his career as a Box Office Manager~~PCAOB atID: Expo 67 (Garden of Stars). In 1969 he joined the National Arts Centre where in 1975 he developed the first computerized subscription/season ticketing system in North America. In 1984, he made the transition to the private sector by co-founding Uniticket to service the Ottawa/Hull Region. Uniticket processed over 1.5 million tickets each year and was sold to Ticketmaster Canada Inc. in 1988. He also co-founded and developed Ticketnet Corporation in 1984, a major new national network for ticketing and shared-resource box office management, which was subsequently sold to AMR in 1986. Mr. Lamarre has acted as a consultant/advisor to a number of Canadian corporations in the development and implementation of leading edge technology and business development. More recently, he fulfilled several executive functions with Comnetix, a leading provider of technology to law enforcement agencies. He then became a Board member and a member of their Audit and Compensation committees and resigned in early 2006 to concentrate his efforts on developing a new venture related to weight loss programs and products. He is currently the President and CEO of Wykanta International Ltd., a company engaged in the production and sale of nutraceutical products. As Vice President of the Company, Mr. Lamarre will be responsible for assisting the President with the general oversight of the Company, its operations and its communications with its shareholders. He will devote all the time necessary as an employee working for the Company as Vice President and a director.6108

~~b) Significant Employees~~Vancouver, Washington

~~None~~January 11, 2023

~~c) Family Relationships~~12

~~There are no family relationships among directors or executive officers~~Item of8. ~~the~~Financial ~~company.~~Statements

d)FINANCIAL STATEMENTS ~~Involvement~~AND inSUPPLEMENTARY ~~certain legal proceedings~~DATA

None

e) Committees

The Company has no standing audit, nominating and compensating committees of the Board of Directors or committees performing similar functions. Under the Sarbanes-Oxley Act of 2002, each public company is required to have an audit committee consisting solely of independent directors and to explain whether or not any independent director is a financial expert. In the event the public company does not have an audit committee, the Board of Directors becomes charged with the duties of the audit committee. Since the enactment of the Sarbanes-Oxley Act of 2002 which was signed into law by President Bush in July 2002, the Company's directors have without success, attempted to obtain independent directors to serve on the Board of Directors and on a newly formed audit committee. In the event the Company is successful in the future in obtaining independent directors to serve on the Board of Directors and on a newly formed audit committee, of which there can be no assurances given, the Board of Directors would first adopt a written charter. Such charter would be expected to include, among other things:

- annually reviewing and reassessing the adequacy of the committees formal charter;

- reviewing the annual audited financial statements with the adequacy of its internal accounting controls;

- reviewing analyses prepared by the Company's management and independent auditors concerning significant financial reporting issues and judgments made in connection with the preparation of its financial statements;

- being directly responsible for the appointment, compensation and oversight of the independent auditor, which shall report directly to the Audit Committee, including resolution of disagreements between management and the auditors regarding financial reporting for the purpose of preparing or issuing an audit report or related work; - reviewing the independence of the independent auditors;

Table of Contents 17

- reviewing the Company's auditing and accounting principles and practices with the independent auditors and reviewing major changes to its auditing and accounting principles and practices as suggested by the independent auditor or its management;

- reviewing all related party transactions on an ongoing basis for potential conflict of interest situations; and

- all responsibilities given to the Audit Committee by virtue of the Sarbanes-Oxley Act of 2002, which was signed into law by President George W. Bush on July 30, 2002.

Code of Ethics

Effective March 3, 2003, the Securities & Exchange Commission requires

registrants like the Company to either adopt a code of ethics that applies to the Company's Chief Executive Officer and Chief Financial Officer or explain why the Company has not adopted such a code of ethics for purposes of item 406 of Regulations S-K, the term "code of ethics" means written standards that are reasonably designed to deter wrong doing and to promote:

- Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships:

- Full, flair, accurate, timely and understandable disclosure in reports and documents that the company files with, or submits to, the Securities & Exchange Commission and in other public communications made by the Company;

- Compliance with applicable governmental law, rules and regulations;

- The prompt internal reporting of violations of the code to an appropriate person or persons identified in the code; and - Accountability for adherence to the code.

The Company has adopted the aforementioned Code of Ethics.

f) Section 16 (a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our officers, directors and persons who beneficially own more than ten percent of a registered class of our equity securities ("ten-percent shareholders") to file reports of ownership and changes in ownership with the Securities and Exchange Commission. Officers, directors and ten-percent shareholders also are required to furnish us with copies of all Section 16(a) forms they file. Based solely on our review of the copies of such forms furnished to us, and written representations that no other reports were required, we believe that during the fiscal year ended November 30, 2013, all of our officers, directors and ten-percent shareholders complied with the Section 16(a) reporting requirements.

ITEM 11. EXECUTIVE COMPENSATION

(a) General

The following current or past Officers or Directors received compensation during fiscal 2011, 2012 or 2013.

2011- Leonard Stella - accrued salary only -$307,500, Bonus-$0 Long Term Compensation-$0

2011- Yehuda Kops - accrued salary only -$307,500, Bonus-$0 Long Term Compensation-$0

2012- Leonard Stella - accrued salary only -$75,000, Bonus-$0 Long Term Compensation-$0

2012- Yehuda Kops - accrued salary only -$75,000, Bonus-$0 Long Term Compensation-$0

2013- Leonard Stella - accrued salary only -$50,000 Bonus-$0 Long Term Compensation-$0

Table of Contents 18

2013- Yehuda Kops - accrued salary only -$50,000, Bonus-$0 Long Term Compensation-$0

There were no bonuses nor long term compensation, whether in cash or shares

Given to any officer of the Company

(b) Options/SAR Grants table

None

(d) Compensation of Directors

Directors do not receive any compensation for services as members of the Board of Directors

(e) Employment Contracts and Termination of Employment and Change-in-Control

The company has no employment contracts with any of its executive officers. As indicated above, certain officers received compensation.

(f) Report on Repricing of options/SAR

None

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth, as of March 14, 2014, information regarding the beneficial ownership of our common stock based upon the most recent information available to us for

· Each person known by us to own beneficially more than five (5%)percent of our outstanding common stock,

· Each of our officers and directors and

· All of our officers and directors as a group.

Name	Number Of Shares Owned Beneficially		% of Total
Purthanol International		70,000,000		37.8	%
2215-B Renaissance Dr
Las Vegas, Nevada
Louis Greco		25,000		.00	%
2711 Centerville Rd Suite 400
Wilmington, De 19808
Former President-Global Biotech
Leonard Stella		2,441,724		1.32	%
2711 Centerville Rd Suite 400
Wilmington, De 19808
CEO-Purthanol Resources
All Directors and Officers		2,466,724		1.32	%

Table of Contents 19

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

As of the date of this report, the Company owes $45,244 to Louis Greco, its former President and Director of the Company for funds lent to the Company.

As of the date of this report, the Company owes $423,181 to Leonard Stella, its CEO, and $423,181 to Yehuda Kops, its CFO, for accrued administrative fees.

All our directors are also executive officers of the Company and, therefore, are not deemed to be independent.

Item 14. Principal Accountant Fees and Service

Audit Fees

For the fiscal year ended November 30, 2013, the aggregate fees billed for professional services rendered by PLS CPA, A Professional Corporation ("independent auditors") for the audit of the Company's annual financial statements totaled approximately $15,000.

Financial Information Systems Design and Implementation Fees

For the fiscal year ended November 30, 2013 there were $-0- in fees billed for professional services by the Company's independent auditors rendered in connection with, directly or indirectly, operating or supervising the operation of its information system or managing its local area network.

All Other Fees

For the fiscal year ended November 30, 2013 there was $0 in fees billed for other service.

PART 4.

ITEM 15. FINANCIAL STATEMENTS AND EXHIBITS

(a) List of Financial statements filed herewith

PURTHANOL RESOURCES LIMITED.

(A company in the development stage)

Report of Independent Registered Accounting Firm		21
Balance Sheets November 30, 2013 and 2012		22
Statement of Operations Year ended November 30, 2013, November 30, 2012 and from inception to November 30, 2013		23
Statement of Shareholders' Equity From inception to November 30, 2013		24
Statement of Cash flows years ended November 30, 2013 and November 30, 2012 and from inception to November 30, 2013		27
Notes to the Financial Statements year ended November 30, 2013		29

Table of Contents 20

PLS CPA, A Professional Corp.

t 4725 MERCURY STREET SUITE 210 t SAN DIEGO t CALIFORNIA 92111 t

t TELEPHONE (858)722-5953 t FAX (858) 761-0341 t FAX (858) 764-5480

t E-MAIL changgpark@gmail.com t

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders

Purthanol Resources Limited

~~(Formerly~~Consolidated ~~Global~~Financial ~~Biotech Corp.)~~Statements

(A November 30, ~~Development~~2022 ~~Stage~~and ~~Company)~~2021

~~We have audited the accompanying balance sheets of~~ Purthanol Resources Limited (Global Biotech Corp.) (the “Company”) as of November 30, 2013 and 2012 and the related statements of operations, changes in shareholders’ equity and cash flows for the years then ended and for the period from November 2, 1998 (inception) through November 30, 2013. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

~~We conducted our audit in accordance~~Consolidated ~~with~~Financial the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.Statements

~~In our opinion, the financial statements~~Year ~~referred~~Ended ~~to above present fairly, in all material respects, the financial position of Purthanol Resources Limited as of~~ November 30, ~~2013~~2022 and 2012, and the result of its operations and its cash flows for the years then ended and for the period from November 2, 1998 (inception) through November 30, 2013 in conformity with U.S. generally accepted accounting principles.2021

~~The financial statements have been prepared~~Table assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company’s losses from operations raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of ~~this uncertainty.~~Contents

~~/s/PLS CPA~~ Report of Independent Registered Public Accounting Firm MICHAEL GILLESPIE & ASSOCIATES, PLLC

_________________________

Balance Sheets		F1

Statements of Operations		F2

Statements of Stockholders' Deficit		F3

Statements of Cash Flows		F4

Notes to Financial Statements		F5

~~PLS CPA, A Professional Corp.~~13

~~March~~PURTHANOL ~~17,~~RESOURCES ~~2014~~LIMITED.

~~San~~Balance ~~Diego, CA. 92111~~Sheet

Table of Contents 21


	As of November 30,
	2022				2021
					( Restated)
NON-CURRENT ASSETS:
Property, plant and equipment, net	$	0			$	0
Total Non-current Assets		0				0
Total Assets	$	0			$	0

LIABILITIES AND SHAREHOLDERS' (DEFICIT)
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	$	41,277			$	39,249
Due to related party (Note 3)		901,748				837,984

Total Current Liabilities		943,025				877,233
Total Liabilities	$	943,025			$	877,233

SHAREHOLDER'S DEFICIT:
Preferred shares (Note 5), $0.0001 par value authorized
80,000,000 shares; no shares issued and outstanding at
November 30, 2022 and November 30, 2021.		-				-
Common shares (Note 5), $0.0001 par value authorized 260,000,000 shares: issued and outstanding 244,038,890 at November 30, 2022 and November 30, 2021.	$	24,403			$	24,403
Shares to be issued		0				0
Additional paid in capital		3,242,350				3,242,350
Accumulated deficit		(4,209,778)				(4,143,986)
Total Shareholders' Deficit			(943,025)	(877,233)
Total Liabilities and Shareholders' Deficit	$	0			$	0

PURTHANOL RESOURCES LIMITED
(Formerly GLOBAL BIOTECH CORP.)
(A Development Stage Company)
Balance Sheets
	As of November 30, 2013			As of November 30, 2012
ASSETS
CURRENT ASSETS
Cash	$	114		$	7
Prepaid Expenses		0			95,581
Notes Receivable		122,200			0
Short Term Investments		197,448			198,160
Total Current Assets		319,762			293,748
Property & Equipment (Net)		—			86,430
Intangible Assets		700,000			—
TOTAL ASSETS	$	1,019,762		$	380,178
LIABILITIES AND STOCKHOLDERS EQUITY
CURRENT LIABILITIES
Bank Overdraft	$	—		$	—
Accounts Payable		974,854			972,551
Notes Payable - (Related Party)		45,244			46,352
Notes Payable		1,286,231			1,248,156
Total Current Liabilities		2,306,329			2,267,059
STOCKHOLDERS EQUITY
Preferred Stock $0.0001 par value, Authorized 80,000,000 shares, 0 shares issued and outstanding as of November 30, 2013 and November 30, 2012		—			—
Common Stock $0.0001 par value, 260,000,000 shares authorized: 164,473,890 shares issued and outstanding as of November 30, 2013 and 82,073,890 as of November 30, 2012		16,447			8,207
Paid-in capital		2,795,550			1,667,790
Deficit accumulated during the development stage		(4,098,564	)		(3,562,878	)
Total Stocksholders Equity		(1,286,567	)		(1,886,881	)
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	$	1,019,762		$	380,178

F-1

~~See~~PURTHANOL RESOURCES ~~Notes to the Financial Statements~~LIMITED.

~~Table~~ Statement of ~~Contents~~Operations 22for the years ended

PURTHANOL RESOURCES LIMITED
(Formerly GLOBAL BIOTECH CORP.)
(A Development Stage Company)
Statement of Operations
	Year Ended November 30, 2013			Year Ended November 30, 2012			November 2, 1998 (Inception) through November 30, 2013
REVENUES	$	312,200		$	—		$	1,257,011
Cost of revenues		—			—			—
GROSS PROFIT		312,200			—			653,948
OPERATING COSTS
Bad debt expense		—			—			120,844
Licensing rights		—			—			700,000
Depreciation expense		—			—			73,274
Marketing expense		—			—			236,266
Professional fees		15,000			11,000			240,295
Selling, general and administrative expense		671,388			215,875			2,403,119
Total operating costs		686,388			226,875			3,773,795
OPERATING (LOSS)		(374,188	)		(226,875	)		(3,119,850	)
OTHER INCOME & (EXPENSES)
Fx		30,787			(20,304	)		(18,419	)
Interest income		9,608			9,148			146,797
Other income (net)		—			—			85,005
Interest expense		(69,755	)		(68,505	)		(578,493	)
Write-down of leasehold improvements		—			—			(2,663	)
Write-up of notes receivable, related parties		—			—			11,435
Impairment Loss		(132,138	)		(86,428	)		(981,969	)
Gain on sale of investment		—			—			359,583
Total Other Income & (Expenses)		(161,498	)		(166,089	)		(978,714	)
NET INCOME (LOSS)	$	(535,686	)	$	(392,964	)	$	(4,098,564	)
BASIC EARNINGS (LOSS) PER SHARE	$	(0.00	)	$	(0.00	)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING		99,842,657			82,073,890

November 30, 2022, and November 30, 2021

See Notes to the Financial Statements


	For the Years Ended November 30,
	2022		2021
OPERATING EXPENSES:			(Restated)
Depreciation	$ -		$ -
Administrative fees		50,000		50,000
Professional fees		13,764		5000
Brokerage fees		2,028		2,028
Total Operating Expenses		65,792		57,028
LOSS FROM OPERATIONS		(65,792)		(57,028)





NET LOSS BEFORE TAXES		(65,792)		(57,028)
INCOME TAX EXPENSE		—		—
NET LOSS	$	(65,792)	$	(57,028)
Basic and diluted weighted average common shares outstanding		244,038,890		244,038,890
Basic and diluted (loss) per common share	$	(0.00)	$	(0.00)

~~Table of Contents 23~~F-2

PURTHANOL RESOURCES LIMITED
(Formerly GLOBAL BIOTECH CORP.)
(A Development Stage Company)
Statement of Stockholders' Equity (Deficit)
From November 2, 1998 (inception) through November 30, 2013
	Common Shares		Common Stock		Additional Paid-in Capital			Stock Subscription Receivable			(Deficit) Accumulated During the Development Stage			Total
Balance, November 30, 1998		0		—		—			—			—			—
Stock issued on April 30, 2000 for cash		10,400,000		1,040		258,961			(103,739	)					156,262
Stock issued on April 30, 2000 for settlement of equipment purchase		600,000		60		14,940									15,000
Stock issued May 29, 2000 in exchange for 5,000,000 shares of Millenia Hope, Inc.		35,700,000		3,570		125,908									129,478
May 31, 2000 - collection on subscription									20,408						20,408
June 30, 2000 - collection on subscription									83,331						83,331
Net loss for November 2, 1998 (inception) to November 30, 2000												(69,231	)		(69,231	)
Balance, November 30, 2000		46,700,000		4,670		399,809			—			(69,231	)		335,248
Stock issued on September 15, 2001 for cash		30,000		3		119,997			(120,000	)					—
Stock issued on November 21, 2001 for cash		380,000		38		189,962			(190,000	)					—
Net loss for the year ended November 30, 2001												(1,679	)		(1,679	)
Balance November 30, 2001		47,110,000		4,711		709,768			(310,000	)		(70,910	)		333,569
Stock issued on December 5, 2001 in exchange for payment of consulting fees		82,500		8		16,492									16,500
Stock issued on May 13, 2002 in exchange for professional fees		205,200		21		51,354									51,375
September 4, 2005 - collection on subscription						(112,500	)		112,500						—
Stock issued October 14, 2002 in exchange for payment on consulting fees		10,000		1		1,999									2,000
November 10, 2012 - collection on subscription						(95,000	)		95,000						—
Net loss for the year ended November 30, 2002												(141,693	)		(141,693	)
Balance, November 30, 2002
Rounding		300													—
Stock issued December 1, 2002 in exchange for marketing expense		250,000		25		24,975									25,000

PURTHANOL RESOURCES LIMITED.

~~Table~~ Statement of ~~Contents~~Shareholder’s 24Equity (Deficit) for the Years Ended

February 28, 2003 - collection on subscription				23,750			23,750
May 31, 2003 - collection on subscription				23,750			23,750
August 31, 2003 - collection on subscription				23,750			23,750
Stock issued October 20, 2003 in exchange for marketing expense	350,000	35	17,465				17,500
Stock issued October 20, 2003 in exchange for notes payable	257,500	26	12,849				12,875
November 30, 2003 - collection on subscription				31,250			31,250
Net loss for the year ended November 30, 2003					(715,903	)	(715,903	)
Balance, November 30, 2003	48,265,500	4,827	627,402	—	(928,506	)	(296,277	)
Net loss for the year ended November 30, 2004	—	—	—	—	(12,936	)	(12,936	)
Balance, November 30, 2004	48,265,500	4,827	627,402	—	(941,469	)	(309,240	)
Net loss for the year ended November 30, 2005					142,417		142,417
Balance, November 30, 2005	48,265,500	4,827	627,402	—	(799,052	)	(166,823	)
Stock issued March 1, 2006 in exchange for services	1,000,000	100	900	—	—		1,000
Net loss for the year ended November 30, 2006	—	—	—	—	(47,203	)	(47,203	)
Balance, November 30, 2006	49,265,500	4,927	628,302	—	(846,255	)	(213,026	)
Stock issued August 15, 2007 in exchange of Property & Equipment & Goodwill	18,000,000	1,800	718,200	—	—		720,000
Net loss for the year ended November 30, 2007	—	—	—	—	(376,336	)	(376,336	)
Balance, November 30, 2007	67,265,500	6,727	1,346,502	—	(1,222,591	)	130,638
Net loss for the year ended November 30, 2008	—	—	—	—	(63,371	)	(63,371	)
Balance, November 30, 2008	67,265,500	6,727	1,346,502	—	(1,285,962	)	67,267
Net loss for the year ended November 30, 2009					(210,712	)	(210,712	)
Balance, November 30, 2009	67,265,500	6,727	1,346,502	—	(1,496,674	)	(143,445	)
Stock issued for services December 18, 2009	333,000	33	83,300	—	—		83,333
Stock issued for services February 18, 2010	63,490	6	18,310	—	—		18,316
Net loss for the year ended November 30, 2010	—	—	—	—	(575,562	)	(575,562	)
Balance, November 30, 2010	67,661,990	6,766	1,448,112	—	(2,072,236	)	(617,358	)
Stock issued for services January 13, 2011	7,700,000	770	153,230	—	—		154,000
Stock issued for services October 20, 2011	2,103,510	210	20,825	—	—		21,035

November 30, 2022, and 2021(Restated)

Table of Contents 25


	Common Stock				Shares To be		Additional Paid in		Accumulated
	Shares		Amount		Issued		Capital		Deficit			Total
Balance as of November 30, 2020		244,038,890	$	24,403		-	$	3,242,350	$	(4,086,958	)	$	(820,205	)

Shares to be issued						0							0

Net loss 2021				-		-		-		(57,028	)		(57,028	)

Balance as of November 30, 2021		244,038,890	$	24,403		0	$	3,242,350	$	(4,143,986	)	$	(877,233	)
Net loss 2022				-		-		-		(65,792	)		(65,792	)
Balance as of November 30, 2022		244,038,890	$	24,403	$	0	$	3,242,350	$	(4,209,778	)	$	(943,025	)

Stock issued for services November 1, 2011	4,608,390	461	45,623	—	—		46,084
Net loss for the year ended November 30, 2011	—	—	—	—	(1,097,678	)	(1,097,678	)
Balance, November 30, 2011	82,073,890	8,207	1,667,790	—	(3,169,914	)	(1,493,917	)
Net loss for the year ended November 30, 2012					(392,964	)	(392,964	)
Balance, November 30, 2012	82,073,890	8,207	1,667,790	—	(3,562,878	)	(1,886,881	)
Stock issued for assets & costs of goods September 10, 2013	70,000,000	7,000	693,000	—	—		700,000
Stock issued for services September 23, 2013	2,400,000	240	35,760	—	—		36,000
Stock issued for services October 4, 2013	10,000,000	1,000	399,000	—	—		400,000
Net loss for the year ended November 30, 2013					(535,686	)	(535,686	)
Balance, November 30, 2013	164,473,890	16,447	2,795,550	—	(4,098,564	)	(1,286,567	)

F-3

~~See~~PURTHANOL RESOURCES ~~Notes to the Financial Statements~~LIMITED.

~~Table~~ Statement of ~~Contents~~Cash-flows 26for the years ended

PURTHANOL RESOURCES LIMITED
(Formerly Global Biotech Corp.)
(A Development Stage Company)
Statements of Cash Flows
							November 2, 1998
							(inception)
	Year Ended			Year Ended			through
	November 30,			November 30,			November 30,
	2013			2012			2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(535,686	)	$	(392,964	)	$	(4,098,564	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense								73,274
Common stock issued for services		436,000			—			872,143
Gain on sale of Investment								(359,583	)
Impairment Loss		132,138			86,428			981,969
Write-down of leasehold improvements								2,663
Write-down of notes receivable								(11,435	)
Accrued interest expense - note payable		69,755			68,505			469,005
Accrued interest income - notes receivable		(9,608	)		(9,148	)		(141,271	)
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable & prepaids		49,873			49,868			(45,708	)
(Increase) decrease in notes receivable		(111,880	)		(6,009	)		(578,068	)
Increase (decrease) in accounts payable		2,303			179,650			974,854
Net Cash Provided by (Used in) Operating Activities		32,895			(23,670	)		(1,860,721	)
CASH FLOWS FROM INVESTING ACTIVITIES
Net sale (purchase) of fixed assets		—			—			(60,937	)
Purchase of short term investments		—			—			(168,560	)
Proceeds from sale of investment shares		—			—			489,061
Net Cash Provided by (Used in) Investing Activities		—			—			259,564
CASH FLOWS FROM FINANCING ACTIVITIES
Issuance of common stock					—			156,262
Payment of common stock subscription receivable					—			206,239
Proceeds from-(payment) notes payable		(32,788	)		23,668			1,238,770
Net Cash Provided by (Used in) Financing Activities		(32,788	)		(2	)		1,601,271
Net Increase (Decrease) in Cash		107			9			114
Cash at Beginning of Year		7			—			—

November 30, 2022, and November 30, 2021

Table of Contents 27


	For the Years Ended November 30,
	2022			2021
				(Restated)
CASH FLOWS FROM OPERATING ACTIVITIES

Net income (loss) for the year	$	(65,792	)	$	(57,028	)
Adjustments to reconcile net loss to net cash used in operating activities:


Changes in operating assets/liabilities:
Accounts payable and accrued liabilities		2,028			2,028
Net cash used in operating activities		(63,764	)		(55,000	)

CASH FLOWS FROM FINANCING ACTIVITIES
Due to related parties		63,764			55,000
Net Cash Provided by Financing Activities		63,764			55,000

NET INCREASE (DECREASE) IN CASH RESOURCES		—			—
CASH - Beginning of Year		—			—
CASH - End of Year	$	—		$	—
SUPLEMENTAL CASHFLOW DISCLOSURE
CASH paid for interest		—			—
CASH paid for income taxes	$	—		$	—

Cash at End of Year	$	114	$	7	$	114
Supplemental Cash Flow Disclosures:
Cash paid during period for interest	$	—	$	—
Cash paid during period for taxes	$	—	$	—
Non-Cash flows activities
Shares issued for Intangible Assets	$	700,000			$	700,000
Shares issued for Property & Equipment		—		—		600,000
Shares issued for Goodwill		—		—		115,000
Note receivable -related party offset with Note payable		—		—		181,878
Note receivable exchanged for Goodwill		—		—		216,261
	$	700,000		—	$	1,818,139

F-4

~~See~~ Notes to the Financial ~~Statements~~Statement for the Year Ended November 30, 2022

~~Table~~NOTE 1 of– ~~Contents~~NATURE 28OF OPERATIONS

PURTHANOL RESOURCES LIMITED (formerly GLOBAL BIOTECH CORP.) (the ``Company``) was incorporated in the State of Delaware on November 2, 1998, to be an Application Service provider in the E-Health sector. On March 5, 2003, this business was sold, market, unsuccessfully. On February 25, 2005, it discontinued its vehicle tracking business. On August 15, 2007, the Company entered the oxygenated beverage market. The Company changed its mission and its objective was to produce Bio fuel alternatives, via the acquisition of the Purthanol process in September. 2013 and the acquisition of Biocardel Quebec in December 2013. The Company changed its name from Global Biotech Corp. to Purthanol Resources Limited on September 30, 2013. Currently the Company has not been operating, and has been inactive since 2015. There are no operations, sales, and activities as far as marketing and production, and the Company is operating out Laval, Quebec, Canada.

~~(formerly~~NOTE 2 ~~GLOBAL~~– ~~BIOTECH~~SUMMARY ~~CORP.)~~OF SIGNIFICANT ACCOUNTING POLICIES

(Aa. Basis ~~Development~~of ~~Stage Company)~~Presentation

Notes to the Financial Statements

As of November 30, 2013

NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS

PURTHANOL RESOURCES LIMITED (formerly GLOBAL BIOTECH CORP.) (the ``Company``) was incorporated in the State of Delaware on November 2, 1998 to be an Application Service provider in the E-Health sector. On March 5, 2003 this business was sold, market, unsuccessfully. On February 25, 2005 it discontinued its vehicle tracking business. On August 15, 2007 the Company entered the oxygenated beverage market. Global’s current mission is to use the Purthonal process methodology, acquired in October 2013, to produce an ethanol fuel alternative. The Company changed name form Global Biotech Corp. to Purthanol Resources Limited on September 30, 2013

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

a. Accounting Method

The Company's policy is to use the accrual method of accounting to prepare and present financial statements, which conforms to US generally accepted accounting principles ("GAAP'). The company has elected a November 30 year- end.

b. Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three ~~months~~ months or less and bank indebtedness to be cash and cash equivalents. Highly liquid investments are valued at quoted market ~~prices.~~

c. Use ~~Estimates~~of ~~and Adjustments~~Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could differ from those estimates. Significant estimates made by management are, among others, reliability of long-lived assets and useful life of fixed asset. Management reviews its estimates on a quarterly basis and, where necessary, makes adjustments prospectively.

~~Significant estimates made by management are, among others, realizability of long-lived~~d. ~~assets~~Property, ~~and~~Plant ~~deferred taxes. Management reviews its estimates on a quarterly basis~~ and, ~~where necessary, makes adjustments prospectively.~~Equipment

dProperty, plant and equipment are recorded at cost less accumulated depreciation and any impairment. ~~Basis~~The cost of ~~Presentation~~an asset comprises its purchase price and ~~Considerations~~any ~~Related~~directly attributable costs of bringing the asset to ~~Continued~~its ~~Existence~~present ~~(going~~working ~~concern)~~condition and location for its intended use. Repairs and maintenance costs are normally expensed as incurred.

~~The~~When assets ~~Company's~~are ~~financial~~retired ~~statements~~or ~~have~~disposed ~~been~~of, ~~presented~~the oncost ~~the~~and ~~basis~~accumulated ~~that~~depreciation itare isremoved afrom ~~going concern~~the accounts, ~~which~~and ~~contemplates~~any ~~the~~resulting ~~realization~~gains ofor ~~assets~~losses are ~~and~~included in the ~~satisfaction~~statement of ~~liabilities~~income (loss) in the ~~normal~~reporting ~~course~~period of ~~business~~disposition.

~~The Company's management intends to raise additional operating funds through operations,~~Depreciation ~~and~~is ~~debt~~calculated oron ~~equity~~a ~~offerings.~~straight-line ~~Management~~basis ~~has~~over ~~yet~~the toestimated ~~decide~~useful ~~what~~life ~~type~~ of ~~offering~~ the ~~Company will use or how much capital the Company will raise~~assets. ~~There is no guarantee that the Company will be able to raise any capital through any type of offerings.~~

e. Going ~~Fair Value of Financial Instruments~~Concern

~~Table~~The Company's financial statements have been presented on the basis that it is a going concern, which contemplates the realization of ~~Contents~~assets 29and the satisfaction of liabilities in the normal course of business. The Company's management intends to raise additional operating funds through operations, and debt or equity offerings. Management has yet to decide what type of offering the Company will use or how much capital it will raise. There is no guarantee that the Company will be able to raise any capital through any type of offerings.

ASC 820, Fair Value Measurements and Disclosures, defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability.F-5

f. Fair Value of Financial Instruments

ASC 820, Fair Value Measurements and Disclosures , defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

Fair Value Hierarchy

ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:

Level 1 applies to assets and liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.

Level 2 applies to assets and liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance:

• Determining which instruments are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates, maturity, issuer, credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed most similar to the security being priced; and

• Determining whether a market is considered active requires management judgment.

Level 3 applies to assets and liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the Company believes the fair value of its financial instruments reported in the consolidated balance sheets consisting of accounts payable and accrued expenses approximate their carrying values due to the relatively short maturity of these instruments.

~~The Company believes the fair value of its financial instruments consisting of cash,~~g. ~~short~~Earnings ~~term~~(Loss) ~~investment,~~Per ~~and accounts payable approximate their carrying values due to the relatively short maturity of these instruments.~~Share

f. Property & Equipment

Property is stated at cost. Additions, renovations, and improvements are capitalized. Maintenance and repairs, which do not extend asset lives, are expensed as incurred.

g. Depreciation

Depreciation is provided on a straight-line basis over the estimated useful lives, 5 years for tenant improvements, and 5 - 7 years for equipment.

h. Impairment of Long-Lived Assets

Long-lived assets held and used by the Company are reviewed for possible impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the estimated undiscounted cash flows, expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of such assets..

Table of Contents 30

i. Revenue Recognition and Deferred Revenue

The Company's revenues recognized from inception to November 30, 2013 were software consultation. Revenue, in respect of all services described, is recognized on completion of services, when collectability is reasonably assured.

j. Foreign Currency Exchange

We record our transactions in US dollars.

Foreign currency accounts have been translated as follows:

• Monetary items - at exchange rates in effect at the balance sheet date • Non-monetary item - at exchange rates in effect of the dates of transactions • Revenue and expenses - at average exchange rate prevailing during the year.

Gains and losses arising from foreign currency translation are included in income.

k. Earning (Loss) Per Share

The Company computes net income (loss) per share in accordance with ASC 260, Earnings per Share. ASC 260 specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. The Company has adopted the provisions of ASC 260 effective November 2, 1998 (inception).

Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company.

~~l. Stock~~F-~~Based Compensation~~6

~~The Company records stock-based compensation in accordance with ASC 718, Compensation – Stock Based Compensation, using the fair value method~~h. ~~All transactions in which goods or services are the consideration~~ ~~received~~Income for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.Taxes

mWe account for income taxes in accordance with ASC 740 - Income Taxes, which requires us to provide a net deferred tax asset/liability equal to the expected future tax benefit/expense of temporary reporting differences between book and tax accounting methods and any available operating loss or tax credit carry forwards. ~~Convertible~~Tax ~~Debt~~law and rate changes are reflected in income in the period such changes are enacted. We record a valuation allowance to reduce the deferred tax assets to the amount that is more likely than not to be realized. We include interest and penalties related to income taxes, including unrecognized tax benefits, within the provision for income taxes.

InOur income ~~accordance~~tax ~~with~~returns ~~Codifications~~are ~~topic~~based ~~470 ”Debt~~on ~~with~~calculations ~~conversion~~ and ~~Other~~assumptions ~~Options”~~that ~~the~~are ~~Company~~subject ~~evaluates~~to ~~debt~~examination ~~securities~~by ~~(“Debt”)~~the ~~for~~Internal ~~beneficial conversion~~Revenue ~~features.~~Service Aand ~~beneficial~~other tax ~~conversion~~authorities. ~~feature~~In isaddition, ~~present~~the ~~when~~calculation ~~the~~of ~~conversion~~our ~~price~~tax ~~per~~liabilities ~~share~~involves isdealing ~~less~~with ~~than~~uncertainties in the ~~market~~application ~~value~~ of ~~the~~complex tax ~~common~~regulations. ~~stock~~We atrecognize ~~the~~liabilities ~~commitment~~for ~~date.~~uncertain ~~The~~tax ~~intrinsic~~positions ~~value~~based ofon ~~the~~a ~~feature~~two-step isprocess. ~~then~~The ~~measured~~first asstep ~~the~~is ~~difference~~to ~~between~~evaluate the ~~conversion~~tax ~~price~~position ~~and~~for ~~the~~recognition ~~market~~by ~~value~~determining (if the ~~“Spread”)~~weight ~~multiplied~~of byavailable ~~the~~evidence ~~number~~indicates ofthat ~~shares~~it ~~into~~is ~~which~~more ~~the~~likely ~~Debt~~than isnot ~~convertible~~that the position ~~and~~will isbe ~~recorded~~sustained ason ~~debt~~audit, ~~discount~~including ~~with~~resolution anof ~~offsetting~~related ~~amount~~appeals ~~increasing~~or ~~additional~~litigation ~~paid-in-capital~~processes, if any. The ~~debt~~second ~~discount~~step is ~~accreted~~ to ~~interest~~measure ~~expense over~~ the tax ~~term~~benefit ofas the ~~Debt~~largest ~~with~~amount ~~any~~that ~~unamortized~~is ~~discount~~more ~~recognized~~than as50% likely ~~interest~~of ~~expense~~being realized upon ~~conversion of the Debt~~settlement. IfWhile awe ~~debt~~believe ~~security~~we ~~contains~~have ~~terms~~appropriate support ~~that~~for ~~change upon~~ the ~~occurrence~~positions oftaken aon ~~future~~our ~~event~~tax ~~the~~returns, ~~incremental~~we ~~intrinsic~~regularly ~~value is~~assess ~~measured as~~ the ~~additional~~potential ~~number~~outcomes of ~~issuable~~examinations ~~shares~~by ~~multiplied~~tax byauthorities in determining the ~~commitment~~adequacy ~~date~~of ~~market~~our ~~value~~provision ~~and~~for isincome ~~recognized~~taxes. asWe ~~additional debt~~continually ~~discount~~assess ~~with~~the anlikelihood ~~offsetting~~and amount ~~increasing~~of ~~additional~~potential ~~paid-in-capital~~adjustments and ~~upon~~adjust the ~~future~~income ~~event~~tax ~~occurrence.~~provision, ~~The~~income ~~total~~taxes ~~intrinsic value~~payable ofand ~~the~~deferred ~~feature~~taxes isin ~~limited~~the toperiod in which the ~~proceeds~~facts ~~allocated~~that give rise to ~~the~~a ~~Debt~~revision become ~~instrument~~known.

ni. Long-lived ~~Recent Accounting Pronouncements~~Assets

~~The~~We follow ~~Company~~ASC ~~has~~360-10-15-3, ~~implemented~~Impairment ~~all~~or ~~new~~Disposal ~~accounting~~of Long-lived Assets, which established a “primary asset” approach to determine ~~pronouncements~~the ~~that~~cash ~~are~~flow inestimation ~~effect~~period for a group of assets and liabilities that ~~may~~represents ~~impact~~the ~~its~~unit ~~financial~~of ~~statements~~accounting for a long-lived asset to be held and ~~does~~used. Long-lived ~~not~~assets ~~believe~~to ~~that~~be ~~there~~held and used are ~~any~~reviewed ~~other~~for ~~new accounting~~impairment ~~pronouncements~~whenever ~~that~~events ~~have~~or ~~been~~changes ~~issued~~in circumstances indicate that ~~might~~the ~~have~~carrying amount of an asset may not be recoverable. The carrying amount of a ~~material~~long-lived ~~impact~~asset onis ~~its~~not ~~financial~~recoverable ~~position~~if it orexceeds ~~results~~the sum of ~~operations~~the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.

~~Table~~Recent Accounting ~~of Contents 31~~Standards

~~NOTE~~The Company 3.has ~~GOING~~implemented ~~CONCERN~~ all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting standards that have been issued that might have a material impact on its financial position or results of operations.

~~The~~NOTE ~~accompanying~~3 ~~financial~~- ~~statements~~DUE ~~have been~~TO ~~prepared~~RELATED assuming that the Company will continue as a going concern. The Company generated net losses of $535,686 for the year ended November 30, 2013 and a net loss of $4,098,564 during the period from November 2, 1998 (inception) through November 30, 2013. At November 30, 2013 the Company had negative working capital of $1,986,567 and stockholders’ deficit of $1,286,567. This condition raises substantial doubt about the Company's ability to continue as a going concern. The Company's continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.PARTY

The amounts ~~officers~~due ~~and~~to ~~directors~~the related party are ~~committed~~$901,748 and to$837,984 ~~help~~respectively infor 2022 ~~raising~~and ~~funds~~2021 which torepresent annual ~~fill~~unpaid management accumulated ~~any~~fees of ~~operating~~$50,000 ~~cash~~owed ~~flow~~to ~~shortages~~the CEO, ~~during~~in ~~the~~addition ~~next~~to ~~fiscal~~$13,764 ~~year~~paid ~~until~~for ~~the~~professional ~~organization~~fees ~~can~~by ~~generate sufficient~~CEO ~~funds~~for ~~from~~the ~~operations~~year toended ~~meet~~November ~~current~~30, ~~operating~~2022. ~~expenses~~The ~~and~~amount ~~overhead,~~due ~~although~~to ~~there~~related ~~are~~party bears no ~~guarantees~~interest, ~~that~~is ~~this~~unsecured ~~commitment will~~and beis ~~met~~repayable on demand.

NOTE 4. ~~SHORT~~- ~~TERM~~INCOME ~~INVESTMENTS~~TAXES

~~On November 6, 2010, the Company purchased a term deposit in the amount of $163,400~~Income USD, ($172,000CDN) bearing interest rate of 5%. On November 6, 2013 they extended the maturity date to November 6, 2014. As of November 30, 2013 the Company accrued $34,048 USD of interest income. No withdrawals allowed for first 90 days and 90 days early withdrawal notice needed. Early withdrawal interest rate - 1 ½%.Taxes

~~NOTE~~Our Company 5has not filed any federal income tax returns and we are currently not subject to state income tax filing requirements. ~~PROPERTY~~As &of November ~~EQUIPMENT~~30, 2022, we have net operating loss carry forwards, on a book basis, of $4,208, 578 which may be available to reduce various future years' federal taxable income. Future tax benefits which may result from these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, we have recorded a valuation allowance for the deferred tax asset relating to the net operating loss carry forwards.

~~On August 15, 2007 the Company acquired Oxygenation Equipment with a cost of $605,000 in exchange for common shares.~~F-7

	November 30, 2013		November 30, 2012
Oxygenation Equipment	$	605,000	$	605,000
Less: Impairment Loss		605,000		518,570
Net Property and Equipment	$	0	$	86,430

The following table presents the current income tax provision for federal and state income taxes for the years ended November 30, 2022 and 2021:

~~Company~~ Schedule ~~recognized~~of ~~impairment~~Components ~~losses~~ of ~~$86,430~~Income ~~and~~Tax ~~$86,428~~Expense ~~for the years ended November 30, 2013 and 2012, respectively.~~(Benefit)

NOTE 6. INTANGIBLE ASSETS


Current tax provisions:		2022		2021
Federal	$	—	$	—
State	$	—	$	—
Total provision for income taxes	$	—	$	—

OnSchedule ~~September 10, 2013 the Company acquired all the intellectual property, process know-how and methodology, etc. for the production~~ of ~~Athanol~~Effective ~~(the~~Income ~~name~~Tax ~~used~~Rate ~~by Purthanol International for its green- technology ethanol fuel alternative), or any other ethanol fuel alternative produced via the Purthanol Process.~~Reconciliation

~~The cost~~ Reconciliations of the ~~above~~U.S. ~~transaction,~~federal ~~$700,000,~~statutory ~~was~~rate ~~paid~~to bythe ~~Purthanol issuing~~actual ~~from~~tax ~~its~~rate ~~treasury~~for ~~seventy~~the ~~million~~years ~~(70~~ended ~~million)~~November ~~common~~30, ~~shares.~~2021 and 2020:

~~NOTE~~Schedule 7.of ~~BASIC~~Effective &Income ~~DILUTED~~Tax ~~INCOME~~Rate ~~/ (LOSS) PER COMMON SHARE~~Reconciliation

Basic gain (loss) per common share has been calculated based on the weighted average number of shares of common stock outstanding during the period. Diluted gain (loss) per common share has been calculated based on the weighted average number of shares of common and preferred stock outstanding during the period.


	2022			2021
US federal statutory income tax rate		21.00	%		21.00	%
Increase in valuation reserve		-21.00	%		-21.00	%
Total provision for income taxes		0.00	%		0.00	%

		November 30, 2013			November 30, 2012
Net income (Loss) from operations	$	(535,686	)	$	(392,964	)
Basic income / (loss) per share	$	(0.00	)	$	(0.00	)
Weighted average number of shares outstanding		99,842,657			82,073,890

The components of our deferred tax assets as of November 30, 2021 and 2020 consisted of the following:

~~Table~~ Schedule of ~~Contents~~Deferred 32Tax Assets and Liabilities

NOTE 8. NOTES PAYABLE

	2022			2021
Net operating losses carry forwards	$	4,209,778		$	4,143,986
Less: valuation allowance	$	(4,209,778	)	$	(4,143,986	)
Net deferred tax assets	$	—		$	—

~~Note~~During the ~~payable~~year asended November 30, 2022, the valuation reserve increased $65,792 compared to an increase of ~~November~~$57,028 during the year ended November 30, ~~2013~~2021. In assessing the recovery of the deferred tax assets, management considers whether it is more likely than not that our Company will not realize some portion or all of the deferred tax assets. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. Management considers the scheduled reversals of future deferred tax assets, projected future taxable income, and ~~2012~~tax ~~consist~~planning strategies in making this assessment. As a result, management determined, as of November 30, 2022, that it was more likely than not that the ~~following:~~deferred tax assets would not be realized.

		2013		2012
Note payable to: Millenia Hope Inc. unsecured, with annual interest rate 7%.	$	652,110	$	608,392
Third parties, unsecured with annual interest of 4%, commencing July 1, 2009		105,063		107,063
Convertible note payable to third parties with annual interest of 2%, commencing March 1, 2011 Loan is convertible to common shares of Global Biotech at par to the lowest daily trading price of the shares on the conversion request date		205,319		213,612
Convertible note payble to third parties with annual interest of 8%, commencing April 30, 2009 Loan is convertible to common shares of Global Biotech at the lesser of $1.00 per share or the average closing price of the shares for the 5 business days prior to conversion		323,739		319,089
	$	1,286,231	$	1,248,156

As noted above, we have not filed any federal tax returns, but we plan on bringing our tax filings current as soon as it is practical.

~~Included in the Notes payable is Millenia Hope due $652,110, who~~NOTE ~~had~~5 ~~a common officer with the company, Leonard Stella.~~– STATEDCAPITAL

~~There are no beneficial conversion features because the Company has conversion right.~~Authorized:

~~NOTE~~260,000,000 authorized 9.voting ~~LICENSING~~common shares ~~RIGHTS~~and 80,000,000 preferred shares authorized: 244,038,890 Common voting shares have been issued as of November 30, 2022, and November 30, 2021, respectively.

OnThere are ~~October 11~~80, ~~2013~~000,000 ~~Purthanol~~authorized ~~Quebec,~~preferred anshares ~~arm’s~~with ~~length~~a ~~corporation, acquired~~par ~~from~~value ~~the Company the rights to use the Purthanol Process to extract ethanol, in the Province~~ of ~~Quebec, Canada for~~ $~~312,200~~0. ~~All~~0001 ~~sales~~that ~~of said extracted ethanol~~ are tonon bevoting ~~done~~in ~~through~~terms ~~Purthanol~~of ~~Resources and the gross profit on these sales, less standard distribution and delivery costs, will be split on a 50-50 basis between the 2 companies. The Company recognized $312,200 as revenue.~~rights

~~NOTE~~No preferred ~~10.~~shares ~~INCOME~~have ~~TAXES~~been issued to date and there are 0 preferred shares outstanding as of November 30, 2022 and November 30, 2021, respectively.

Income taxes are provided in accordance with ASC 740, Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryF-~~forwards. Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities.~~8

~~The net operating loss expires twenty~~NOTE ~~years~~6 ~~from~~– SUBSEQUENT the date the loss was incurred. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.EVENT

No events ~~portion~~have ofoccurred ~~the~~subsequent ~~valuation allowance will be allocated~~ to ~~reduce~~the ~~goodwill~~balance orsheet ~~other~~date ~~non-current~~and ~~intangible~~through ~~asset~~the date of anthis ~~acquired~~filing ~~entity.~~that ~~There~~would ~~are~~require noadjustment ~~temporary~~to ~~differences~~ or ~~carry-forward~~disclosure in ~~tax effects that would significantly effect~~ the ~~Companies~~financial ~~deferred tax asset~~statements.

~~Utilization of the net operating losses and~~The ~~credit~~same ~~carry-forwards~~types ~~may be subject to a substantial annual limitation due to the "change in ownership" provisions~~ of ~~the~~adjustments ~~Internal~~were ~~Revenue~~made ~~Code~~for ~~of 1986. The annual limitation may result in~~ the ~~expiration~~year ofended ~~net operating losses and credits before utilization. At~~ November 30, ~~2013~~2022, reflecting the ~~Company~~same ~~had~~above ~~net~~rules ~~operating~~and ~~losses~~principles ~~carry-forward~~in ~~of $4,098,564. The tax benefits resulting~~accordance ~~for~~with ~~these~~US ~~losses have been estimated as follows:~~GAAP.

~~Table~~NOTE 7 of- ~~Contents 33~~RESTATEMENT

		November 30, 2013
Gross income tax benefit	$	1,434,000
Valuation Allowance		1,434,000
Net Income Tax Benefit	$	0
Deficit - December 1, 2012	$	(3,562,878	)
Net Loss for Year ended November 30, 2013		(535,686	)
Deficit - November 30, 2013	$	(4,098,564	)

Adjustments were made for the year ended November 30, 2021 to reflect the rules and principles in accordance with US GAAP.

~~NOTE~~The balance 11sheet for the year ended November 30, 2021 was restated. ~~STOCK~~Property ~~TRANSACTIONS~~Plant and Equipment was debited

OnIn the ~~September~~amount 10of $129,167 ~~2013~~to ~~the~~reverse ~~Company~~total ~~issued~~accumulated 70depreciation. Property Plant and Equipment was credited by $250,000~~,000~~. ~~common~~Total ~~shares~~Assets as ina ~~settlement~~ result of ~~property~~these ~~and~~adjustments ~~equipment~~were ofcredited by $~~700~~120,~~000~~833.

OnAccounts payable ~~September~~and ~~23,~~accrued ~~2013~~liabilities ~~the~~were ~~Company~~debited ~~issued 2,400,000~~by ~~common~~$1200 ~~shares~~because inof ~~settlement~~November of30 ~~consulting~~2020 ~~fees~~foreign ofexchange ~~$36,000~~adjustments being carried forward as mentioned earlier.

OnDue to ~~October~~related 4,party ~~2013~~was ~~the~~credited ~~Company~~by ~~issued~~$5000 ~~10,000,000 common~~to ~~shares~~take ininto ~~settlement~~consideration offees ~~consulting~~paid ~~fees~~to ofRon ~~$400,000~~McIntyre which were paid personally by CEO Leonard Stella.

AsTotal liabilities ofwere ~~November~~credited 30by $3,800 ~~2013~~as a result of these adjustments to the ~~Company~~liabilities ~~had~~in ~~164,473,890 shares~~the ofBalance ~~common~~Sheet ~~stock~~of ~~issued~~November ~~and~~30, ~~outstanding~~2021.

~~NOTE~~Shares to ~~12.~~be ~~STOCKHOLDERS'~~issued ~~EQUITY~~ in amount of $250,000 US were debited since the payment in the form of Shares to be issued was never satisfied for the purchase of equipment as can be seen in the section Shareholders Equity of the Balance Sheet as of November 30, 2021.

~~The~~Additional paid ~~stockholders'~~in ~~equity~~capital ~~section~~was debited for a total of ~~the~~$82,883 ~~Company~~as ~~contains~~a result of adding $29,154 in imputed interest for the ~~following classes~~year ofended ~~capital~~November ~~stock~~30,2021 to $53,729 as of November 30, ~~2013~~2020 ~~and~~bringing ~~2012:~~the value of Additional Paid in Capital to $3,242,350.

~~Common~~Accumulated Deficit ~~stock,~~was $reduced ~~0.0001~~and ~~par~~credited ~~value;~~by ~~260~~$208,~~000,000 shares~~250 ~~and~~taking ~~260,000,000~~into ~~shares~~account ~~authorized~~adjustment ~~November~~of ~~30,~~credit ~~2012~~of ~~and 2013: 82~~$74,~~073,890~~154 ~~shares~~for ~~issued~~the ~~and~~year ~~outstanding~~ended ~~as of~~ November 30, 2021. ~~2012~~Accumulated ~~and~~adjustment ~~164~~of $134,~~473,890~~096 asin of2020 ~~November~~plus 30$74,154 ~~2013~~equals $208,250.

~~Preferred Stock, $0.0001 par value; 80,000,000~~Total ~~shares~~Liabilities ~~authorized~~and asShareholders’ ~~November~~Equity ~~30,~~was ~~2012~~debited ~~and~~by ~~November 30~~$120,833 ~~2013.~~for ~~Zero~~the ~~(0)~~restated ~~shares~~Balance ~~issued~~Sheet ~~and outstanding,~~ as of November 30, ~~2012 and 2013~~2021.

~~NOTE~~The Statement ~~13.~~of ~~RELATED~~Operations ~~PARTY~~for ~~TRANSACTIONS~~the year ended November 30, 2021 was restated to adjust for the following corrections.

AsProfessional fees of ~~November~~$5000 ~~30,~~were ~~2013~~debited for the ~~Company~~Legal ~~owed~~fees ~~two~~paid ofto ~~its~~Ron ~~officers,~~McIntyre ~~Leonard~~in ~~Stella, CEO,~~the ~~and~~amount ~~Yehuda~~of ~~Kops, CFO,~~ $~~846~~5,~~362~~000 ofby ~~administrative fees~~CEO. ~~This amount is included in the Accounts payable.~~

~~The~~Depreciation expense ~~Notes~~of ~~payable related is due to its former President~~$50,000 ~~Louis Greco~~was credited.

~~NOTE~~Interest expense ~~14.~~of ~~SUBSEQUENT~~$29,154 ~~EVENTS~~for year ended November 30, 2021 was credited from Statement of Operations and

~~In accordance with ASC 855,~~Total ~~Subsequent~~Net ~~Events,~~Loss ~~the~~as ~~Company~~a ~~has~~result ~~evaluated subsequent events through the date~~ of ~~issuance~~these ofadjustments ~~the~~was ~~audited~~reduced ~~financial~~by ~~statements. During this period~~$79, ~~the Company had the following subsequent event~~154.

On December 16, 2013, Global acquired 100% of all outstanding shares of Biocardel Quebec, a privately held company, for $5 million, payable $100,000 at signing of the agreement, $2,400,000 in 9 months, as a balance of sale and $2,500,000 in preferred convertible shares, at a 25% discount to the 90 trading F-day average sales price of the common shares, whenever Global chooses to exercise the conversion rights. Biocardel owns a production facility in Richmond, Quebec, that turns biologic oil waste products and byproducts into biodiesel fuel, a commodity in demand in both North America and Europe.9

OnThe tables ~~February~~below ~~25,~~summarize ~~2014~~ the ~~Company~~detailed ~~issued~~adjustments ~~650,000~~for ~~common~~the ~~shares~~year inended ~~settlement~~November ~~of consulting fees of $9~~30,~~750~~ 2021.

~~Table~~The following oftable ~~Contents~~summarizes 34changes made to November 30, 2021 balance sheet

~~(b)~~Schedule ~~List~~ of ~~Exhibits.~~Segment Reporting Information, by Segment

Reports on Form 8-K


		30-Nov-21
Balance Sheet:		As Reported		Adjustment		As Restated
Property, plant, equipment	$	120,833	$	129,167	$	250,000
			$	-250,000	$	-250,000
Total assets	$	120,833	$	-120,833	$	0

Accounts payable and accrued liabilities	$	40,449	$	-1,200	$	39,249
Due to related party		832,984		5,000		837,984
Total liabilities	$	873,433	$	3,800	$	877,233

Shares to be issued	$	250,000	$	-250,000	$	0
Common shares		24,403		—		24,403
Additional paid-in capital	$	3,325,233	$	-82,883	$	3,242,350
Accumulated deficit	$	-4,352,236	$	208,250	$	-4,143,986
Total Stockholders’ Equity	$	-752,600	$	-124,583	$	-877,233
Total liabilities and stockholders’ equity	$	120,833	$	-120,833	$	0

~~Appointment~~The following table summarizes changes made to the year ended November 30, ~~resignation~~2021 Statement of ~~officers/directors~~Operations.

~~Entry~~Quarterly ~~into~~Financial ~~material agreements~~Information

Sarbane Oxley Declarations


	For the year ended November 30, 2021
	As Reported		Adjustment		As Restated
OPERATING EXPENSES Professional fees	$	—	$	5,000	$	5,000
Depreciation		50,000		50,000		0
Administrative Fees		50,000				50,000
Brokerage fees		2,028				2,028
Regulatory Expense

Total Operating Expenses	$	102,028	$	-45.000	$	57,028
OTHER INCOME (EXPENSE)
Interest expense	$	29,154	$	29,154		0
Total Other Income (Expense)
NET LOSS	$	131,182	$	-74,154	$	57,028

~~Table of Contents 35~~23

Quarterly Financial Information Equity


	Common Stock				Shares		Additional Paid in		Accumulated
	Shares		Amount		To be Issued		Capital		Deficit			Total

Balance as of November 30, 2019		244,038,890	$	24,403	$	250,000	$	3,268,328	$	(4,059,275	)	$	(488,793	)
Imputed interest							$	27,751
Net loss 2020				-		-				(161,779	)		(161,779	)
Balance as of November 30, 2020		244,038,890	$	24,403	$	250,000	$	3,296,079	$	(4,221,054	)	$	(650,572	)
Imputed Interest							$	29,154
Net loss 2021										(131,182	)		(131,182	)
Balance as of November 30, 2021		244,038,890	$	24,403	$	250,0000	$	3,325,233	$	(4,352,236	)	$	(752,600	)

Statement of Shareholders Equity ( Deficit) for the year ended November 30,2020 and November 30,2021 was corrected and restated.

To take into account the following adjustments:

Shares to be issued in amount of $250,000 was reversed to become zero, because shares were never issued,

Additional Paid in Capital was debited by $82,833 to correct and cancel imputed interest on amount due to related party.

Additional paid in Capital went from $3,325,233 to $3,242,350 as we can see on restated Statement of Equity (Deficit).

Accumulated Deficit went from $ 4,352, 236 to $ 4,143,986 to correct for net loss in 2020 and net loss in 2021, respectively.

Net loss in 2020 went down from $161,779 to $82,828. And Net loss in 2021 went from $131,182 to $57,028, due to reversal of depreciation, reversal of interest expense, adjustment for professional fees, and correction of regulatory expense because of foreign exchange.

Total Shareholders’ Deficit went from $650,572 in 2020 to $ 820,205 due to all of the above cumulative changes and corrections.

Total Shareholders’ Deficit went from $752,600 in 2021 to $ 877,233 due to all of the above cumulative changes and corrections.

Please see below the Restated Statement of Shareholders Equity ( Deficit) for years ended November 30,2021 and November 30, 2020.

PURTHANOL RESOURCES LIMITED.

Statement of Shareholder’s Equity (Deficit)

for the Years Ended November 30, 2021, and 2020

(Restated)

	Common Stock				Shares		Additional Paid in Capital		Accumulated Deficit
	Shares		Amount		To be Issued							Total



Balance as of November 30, 2019		244,038,890	$	24,403	$	0	$	3,242,350	$	(4,004,130	)	$	(737,377	))
Shares to be issued					$	0							0
Net loss 2020						___________			$	(82,828	)		(82,828	)
Balance as of November 30, 2020		244,038,890	$	24,403	$	0	$	3,242,350	$	(4,086,958	)	$	(820,205	)

Net loss 2021										(57,028	)		(57,028	)
Balance as of November 30, 2021		244,038,890	$	24,403	$	0	$	3,242,350	$	(4,143,986	)	$	(877,233	)

The impact of changes and corrections of errors does not affect the end result of cash flows. Net increase in cash resources remains the same. Cash at beginning and end of year remains zero for the year ended November 30, 2020.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES

TAAD LLP communicated to the Company’s board of directors that the Company must perform additional internal accounting research and provide an accurate restatement form to correct the Company’s mis-stated Form 10 filed with the SEC. TAAD LLP was notified that the Company could not perform additional internal accounting research without unreasonable effort and expense. Further, the Company believed it had presented the footnotes to the financial statements, specifically Note 1 and Note 9, that satisfies the disclosures required by required by ASC 250-10-50-7 through 50-10.

Other than as noted above, during the Company’s fiscal years ended November 30, 2020 and November 30, 2021, the Company has not had any disagreement with TAAD LLP on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures, which disagreement, if not resolved to TAAD LLP’s satisfaction, would have caused TAAD LLP to make reference to the subject matter of the disagreement in their reports on the Company’s financial statements.

During the Company’s fiscal years ended November 30, 2020 and November 30, 2020, there were no other “reportable events” as that term is defined in Item 304(a)(1)(v) of Regulation S-K. TAAD LLP’s report on the Company’s financial statements as of and for the fiscal years ended November 30, 2020 and November 30, 2021 did not contain any adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles.

On June 3, 2022, Purthanol Resources Ltd. appointed MICHAEL GILLESPIE & ASSOCIATES, PLLC

as the Company's new independent registered public accounting firm.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is accumulated and communicated to management including our principal executive officer and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

In connection with this annual report, as required by Rule 13a -15d and 15d-15e under the Securities Exchange Act of 1934, we have carried out an evaluation of the effectiveness of the design and operation of our company’s disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our company’s management, including our company’s principal executive officer and principal financial officer. Based upon that evaluation, our company’s principal executive officer and principal financial officer concluded that as of November 30, 2022 our disclosure controls and procedures were not effective due to the existence of material weaknesses in our internal controls over financial reporting.

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Securities Exchange Act of 1934 as a process designed by, or under the supervision of, the Company’s Principal Executive and Principal Financial officer and effected by the Company’s board of directors, management and other personnel to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:

	1.	Pertains to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and disposition of assets;

	2.	Provide reasonable assurance that transactions are recorded as necessary to permit preparation of our financial statements in accordance with accounting principles generally accepted in the United States of America and receipts and expenditures are being made in accordance with authorizations of management and directors; and

	3.	Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of company assets that could have a material effect on our financial statements.

Management assessed the effectiveness of the Company’s internal control over financial reporting based on the criteria for effective internal control over financial reporting established in SEC guidance on conducting such assessments as of the end of the period covered by this report. Management conducted the assessment based on certain criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. As of November 30, 2022, management determined material weaknesses existed with our internal control over financial reporting as discussed below.

The matters involving internal controls and procedures that the Company’s management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were: (1) lack of a functioning audit committee and lack of a majority of outside directors on the Company's board of directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures; (2) inadequate segregation of duties consistent with control objectives; (3) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements; and (4) ineffective controls over period end financial disclosure and reporting processes. Due to these material weaknesses management concluded that our internal control over financial reporting was not effective as of November 30, 2022.

Material Weakness Discussion and Remediation

Management believes that the material weaknesses set forth in items (2), (3) and (4) above did not have an eeffect on the Company's previous reported financial results. However, management believes that the lack of a functioning audit committee and lack of a majority of outside directors on the Company's board of directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures could result in the Company’s review of its financial statements in the future of being in-effective.

We are committed to improving our financial organization. As part of this commitment, we will create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to the Company. This will be achieved by: i) Appointing one or more outside directors to our board of directors who shall be appointed to the audit committee of the Company resulting in a fully functioning audit committee who will undertake the oversight in the establishment and monitoring of required internal controls and procedures; and ii) Preparing and implementing sufficient written policies and checklists which will set forth procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements.

Management believes that the appointment of one or more outside directors, who shall be appointed to a fully functioning audit committee, will remedy the lack of a functioning audit committee and a lack of a majority of outside directors on the Company's Board. In addition, management believes that preparing and implementing sufficient written policies and checklists will remedy the following material weaknesses (i) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements; and (ii) ineffective controls over period end financial close and reporting processes. Further, management believes that the hiring of additional personnel who have the technical expertise and knowledge will result in proper segregation of duties and provide more checks and balances within the department. Additional personnel will also provide the cross training needed to support the Company if personnel turnover issues within the department occur. This coupled with the appointment of additional outside directors will greatly decrease any control and procedure issues the company may encounter in the future.

We will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

This annual report does not include an attestation report of the company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the company’s registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this annual report.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 under the Exchange Act that occurred during the small business issuer's last fiscal year that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Our executive officers and director are as follows:

Name		Age		Position
Leonard Stella		61		President, Chief Executive Officer, Secretary, Treasurer, Chief Financial Officer and Chairman of the Board of Directors

Business Experience

CURRENT POSITION - Chief Executive Officer, Purthanol Resources Ltd. since February 2014.

2/2014-PRESENT

PREVIOUS POSITION

Chief Executive Officer, Global Biotech Corp

Real Estate Broker license: between 1980 – 1989 and Director and Founder of Trans-Immobilia in Canada and Director and Founder Transaction Realty in New York, USA I was an Assistant and technician to the Director of Personnel at Mount Sinai Hospital in Ste-Agath Quebec for a one-year period between 1984 and 1985. Between 1989 and 1997 owned several restaurants in and around the city of Montreal Quebec. In 1998 until 2012 Mr. Stella was the Founder and Chief Executive Officer of Millenia Hope Inc. (“Millenia”) – Public Pharmaceutical Company – which produced an anti-malarial product – homologated in 18 countries in Africa – produced phyto-chemicals for L’Oreal France, Sederma France, Pierre Fabre Laboratories (France) and Synomex USA. Mr. Stella was also the Chief Operating Officer and founder of Sword Comp Soft of a public company in 1998 to 2003 an IT Company that dealt with the compression of data and information.

Business Development Officer from 2004 to 2012 of Global Biotech Corp – produces the following products Aquaboost, Pet Boost, and Femtra. Global Biotech Corp.

In 2006 Millenia discovered a compound for HIV - CCR5 and RNash enzyme for preventing the body to give entrance and cleave the AIDS virus to human DNA. Millenia was given a grant of 4.6 million dollars with National Institute of Health (NIH) USA along with Rudger and Pittsburgh University.

In 2008 to 2010 Millenia was granted an anti-parasitical compound from the NIH to continue the development of anti-parasitical drugs this project was not funded.

In 2006 to 2012 Mr. Stella was Director and Officer of Pharmateck International Ltd – Distributers of Aquaboost the only water in North America with a DIN (Drug Identification Number) and just acquired 6 NPN (Natural Product Numbers) for nutraceutical health products – sold the process and the NPNs.

In 2009 to 2012 I was a Director and Officer of Genesis Biopharma a partner of Millenia Hope Pharmaceutical Inc. which had a peptide compound licensed by the University of Sherbrooke, in Phase 1A for Pain Neuropathy stemming from complicated Diabetes and Prostate Cancer with Health Canada.

Education

1984 - Bachelor of Arts - McGill University, Montreal Canada

1986 – Graduate Diploma in Business Administration - Concordia University, Montreal Canada

b) Significant Employees. None.

(c) Family Relationships. None.

(d) Involvement in Certain Legal Proceedings.

No officer, director, or persons nominated for such positions, promoter or significant employee has been involved in the last ten years in any of the following:

• Any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time.

• Any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);

• Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities; and

• Being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.

(e) The Board of Directors acts as the Audit Committee and the Board has no separate committees. The Company has no qualified financial expert currently because it has not been able to hire a qualified candidate. Further, the Company believes that it has inadequate financial resources currently to hire such an expert. The Company intends to continue to search for a qualified individual for hire.

(f) Code of Ethics. We do not currently have a code of ethics

Director Independence

Our board of directors is currently composed of one member, Leonard Stella, who does not qualify as an independent director in accordance with the published listing requirements of the NASDAQ Global Market. The NASDAQ independence definition includes a series of objective tests, such as that the director is not, and has not been for at least three years, one of our employees and that neither the director, nor any of his family members has engaged in various types of business dealings with us. In addition, our board of directors has not made a subjective determination as to each director that no relationships exist which, in the opinion of our board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director, though such subjective determination is required by the NASDAQ rules. Had our board of directors made these determinations, our board of directors would have reviewed and discussed information provided by the directors and us with regard to each director’s business and personal activities and relationships as they may relate to us and our management.

Involvement in Legal Proceedings

To our knowledge, there have been no material legal proceedings during the last ten years that would require disclosure under the federal securities laws that are material to an evaluation of the ability or integrity of any of our directors or executive officers.

Potential Conflicts of Interest

We are not aware of any current or potential conflicts of interest with Mr. Stella, other business interests and his involvement with Purthanol Resources Limited.

ITEM 11. EXECUTIVE COMPENSATION

Summary Compensation Table

Purthanol Resources Limited, has made no provisions for paying cash or non-cash compensation to its sole officer and director. No salaries are being paid at the present time, and none will be paid unless and until our operations generate sufficient cash flows.

The table below summarizes all compensation awarded to, earned by, or paid to our named executive officer for all services rendered in all capacities to us for the years ending November 30, 2022 and November 30, 2021.

Summary Compensation of Named Executive Officers

Name and Principal Position

Fiscal Year

Salary ($)

Bonus ($)

Stock Awards

($)

Option Awards

($)

All Other Compensation ($)

Total

($)

Leonard Stella*

President, Chief Executive Officer, Secretary, Treasurer

2022

Leonard Stella*

President, Chief Executive Officer, Secretary, Treasurer

2021

* For the years ended November 30, 2021 and 2022 the Company accrued $50,000 in Management fees owed to Leonard Stella.

Outstanding Equity Awards at Fiscal Year End

We did not pay any salaries in 2022 and 2021. None of our executive officers received any equity awards, including, options, restricted stock, performance awards or other equity incentives during the fiscal year ended November 30, 2022 and November 30, 2021 for Purthanol Resoursces Limited.

Employment Contracts

At this time, Purthanol Resources Limited has not entered into any employment agreements with its sole officer and director. If there is sufficient cash flow available from our future operations, the company may enter into employment agreements with our sole officer and director or future key staff members.

Stock Awards Plan

The company has not adopted a Stock Awards Plan but may do so in the future. The terms of any such plan have not been determined.

Director Compensation

The Board of Directors of the Company has not adopted a stock option plan. The company has no plans to adopt it but may choose to do so in the future. If such a plan is adopted, this may be administered by the board or a committee appointed by the board (the “Committee”). The committee would have the power to modify, extend or renew outstanding options and to authorize the grant of new options in substitution therefore, provided that any such action may not impair any rights under any option previously granted. Purthanol Resources Limited may develop an incentive-based stock option plan for its officers and directors and may reserve up to 10% of its outstanding shares of common stock for that purpose.

The table below summarizes all compensation awarded to, earned by, or paid to our directors for all services rendered in all capacities to us for the period from November 30, 2022, and November 30, 2021.

DIRECTOR COMPENSATION
Name	Fees Earned or Paid in Cash ($)		Stock Awards ($)		Option Awards ($)		Non-Equity Incentive Plan Compensation ($)		Non-Qualified Deferred Compensation Earnings ($)		All Other Compensation ($)		Total ($)
Leo Stella		0		0		0		0		0		0		0

Board Committees

We have not formed an Audit Committee, Compensation Committee or Nominating and Corporate Governance Committee as of the filing of this Annual Report. Our Board of Directors performs the principal functions of an Audit Committee. We currently do not have an audit committee financial expert on our Board of Directors. We believe that an audit committee financial expert is not required because the cost of hiring an audit committee financial expert to act as one of our directors and to be a member of an Audit Committee outweighs the benefits of having an audit committee financial expert at this time.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth certain information with respect to the beneficial ownership of our voting securities by (i) each director and named executive officer, (ii) all executive officers and directors as a group; and (iii) each shareholder known to be the beneficial owner of 5% or more of the outstanding common stock of the Company as of November 30, 2022

Beneficial ownership is determined in accordance with the rules of the SEC. Generally, a person is considered to beneficially own securities: (i) over which such person, directly or indirectly, exercises sole or shared voting or investment power, and (ii) of which such person has the right to acquire beneficial ownership at any time within 60 days (such as through exercise of stock options or warrants). For purposes of computing the percentage of outstanding shares held by each person or group of persons, any shares that such person or persons has the right to acquire within 60 days of November 30, 2022 are deemed to be outstanding but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person. The inclusion herein of any shares listed as beneficially owned does not constitute an admission of beneficial ownership.

Name of Beneficial Owner

Common Shares Owned

Options Exercisable

Common Shares Beneficially owned

Percentage of Class

Leonard Stella (1)

2,441,724

1.001

PURTHANOL INTERNATIONAL(2)

70,000,000

28.684

AMBROSIA ROSEDALE CAPITAL LIMITED(3)

20,000,000

8.195

All officers and Directors as a group (1 person)

2,441,724

1.001

Greater than 5% Shareholders

90,000,000

36.879

(1)

Leonard Stella is Chief Executive Officer, Chief Financial Officer, Secretary and Sole Director of the Company.

(2)

Louis Pharand has sole voting and dispositive power over the shares.

(3)

Jean Marie Rancour has sole voting and dispositive power over the shares.

This table is based upon information derived from our stock records. We believe that each of the shareholders named in this table has sole or shared voting and investment power with respect to the shares indicated as beneficially owned; except as set forth above, applicable percentages are based upon 244,038,890 shares of common stock outstanding as of the date of this registration statement on Form 10.

ITEM 13. CERTAIN RELATIONSHIP AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

Transactions with Related Persons

The amounts due of $901,748 and $837,984 respectively for 2022 and 2021 which represent annual unpaid management accumulated fees of $50,000 owed to the CEO, in addition to $13,764 paid for professional fees by CEO for the year ended November 30, 2022. The amount due to related party bears no interest, is unsecured and is repayable on demand.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

Fees paid to Auditors

Audit Fees

The following table summarizes the fees of MICHAEL GILLESPIE & ASSOCIATES, PLLC and TAAD LLP, our independent registered public accounting firms billed for each of the last two fiscal years for audit services and other services:

Fee Category	2022		2021
Audit Related Fees Paid to Assurance TAAD LLP (1)	$	—	$	19,000
Audit Related Fees Paid to MICHAEL GILLESPIE & ASSOCIATES, PLLC (1)		—		—
All Other Fees		13,550		—

Total Fees	$	13,550	$	19,000

(1) Consists of fees for professional services rendered in connection with the financial statements included in our Annual Report on Form 10-K and quarterly reports on Form 10-Q.

The SEC requires that before our independent registered public accounting firm is engaged by us to render any auditing or permitted non-audit related service, the engagement be either: (i) approved by our Audit Committee or (ii) entered into pursuant to pre-approval policies and procedures established by the Audit Committee, provided that the policies and procedures are detailed as to the particular service, the Audit Committee is informed of each service, and such policies and procedures do not include delegation of the Audit Committee’s responsibilities to management.

We do not have an Audit Committee. Our Board pre-approves all services provided by our independent registered public accounting firm. All of the above services and fees paid for fiscal years 2022 and 2021 were pre-approved by our Board.

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

Please see the “Exhibit Index,” which is incorporated herein by reference, following the signature page for a list of our exhibits.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PURTHANOL RESOURCES LIMITED

	Purthanol Resources Limited

Dated: January 18, 2023	By: /s/ Leonard Stella
	Leonard Stella President and Director Principal Executive Officer Principal Financial Officer Principal Accounting Officer

Date: March 17, 2014		/s/ Leonard Stella
		Leonard Stella, CEO, Director
		(Principal Executive Officer)
		/s/ Yehuda Kops
		Yehuda Kops, CFO, Director
		(Principal Financial and Accounting Officer)
		/s/ Louis Pharand
		Louis Pharand, President, Director

~~Pursuant to the requirements of the Securities Exchange Act of 1934,~~EXHIBIT ~~this report has been signed as of March 17, 2014, by the following persons on behalf of the registrant in the capacities indicated:~~INDEX

Signature Title /s/ Leonard Stella Chief Executive Officer, Director Leonard Stella /s/ Louis Pharand President, Director Louis Pharand /s/ Yehuda Kops Chief Financial Officer, Director Yehuda Kops /s/ Gilles Lamarre Vice President, Director Gilles LamarreExhibit 3.1

~~Table~~ Certificate of ~~Contents~~Amendment 36changing the Company name to Purthanol Resources Limited October 23, 2013. [1]

Exhibit 3.2

Bylaws of Purthanol Resources – formerly known as Sword Comp-Soft Corp as previously filed with the SEC on Form SB2 on January 18, 2001 https://www.sec.gov/Archives/edgar/data/1126162/000089155401500243/d24433_ex3-2.txt

Exhibit 31.1

Certification of Chief Executive Officer pursuant to Rule 13(a)-14(a)/15(d)-14(a) of the Securities Act of 1934*

Exhibit 31.2

Certification of Chief Financial Officer pursuant to Rule 13(a)-14(a)/15(d)-14(a) of the Securities Act of 1934 **


101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

101.SCH		Inline XBRL Taxonomy Extension Schema Document

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Incorporated by reference from the Company’s Form 10 filed with the Commission on October 7, 2022.

** Incorporate by reference from the Company’s Form 10 filed with the Commission on October 7, 2022

* Included in Exhibit 31.1

** Included in Exhibit

Filing Compare · Purthanol Resources Ltd